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ABSTRACT
Health benefits from consuming rice bran oil (RBO) have been extensively studied in
humans. RBO has been shown to decrease cholesterol absorption by inhibiting the oxidation of
the LDL-cholesterol. γ-Oryzanol is one of the RBO components that possess antioxidative
properties; it is a polyphenolic compound resembling tocopherol (vitamin E), which is another
component of RBO. There are evidences that oryzanol has potential applications for enhancing
shelf-life of foods containing fats processed at a high temperature, decreasing the total
cholesterol, LDL-cholesterol and triglyceride levels in plasma lipids, and healing ulcers. In order
to take advantage of the health benefits of oryzanol, food products fortified with oryzanol should
be developed and characterized. Cheddar cheese containing γ-Oryzanol was developed, and the
effects of oryzanol on cheese quality during ripening process were studied. Cheese was stored
for 5 months and drawn every month for quality evaluation of color, texture, microbial growth,
aroma development, bacterial identification by polymerase chain reaction, oryzanol retention,
moisture content and free fatty acid profile. The consumer acceptance was evaluated after 5
months of maturation. The results indicated that by adding γ-Oryzanol to cheddar cheese
changes occurred in the quality, but, they were not significant when stored for up to 4 months,
and the γ-Oryzanol was well retained. Consumers were able to differentiate the cheddar cheese
containing γ-Oryzanol from the control containing no γ-Oryzanol. Overall appearance, texture,
taste and hardness were the most discriminatory sensory attributes. There was a significant
positive increase 0.13 to 0.30 times higher in the purchase intent of cheddar cheese containing γOryzanol after consumers had been informed about the health benefits of oryzanol. Overall
liking was the attribute critical to purchase intent and the most important attribute that changed
the acceptability of the cheese. Consumers preferred the cheese with γ-Oryzanol less than the

xiv

control but were willing to buy it and compromise the overall liking of cheese merely to get the
health benefits of the product. Further studies need to be done to determine the direct effects of
cheddar cheese containing γ-Oryzanol in human health, and to optimize the homogenization and
fortification of γ-Oryzanol when incorporated in cheese products.

xv

CHAPTER 1. INTRODUCTION
The functional foods industry is evolving at a rapid pace. Consumer interest in healthy
eating and self-medication is not just a passing fad. The growing importance of health and
wellness has significantly altered consumption and buying behaviors. In the United States and
some other developed countries, functional and/or nutraceutical foods have already become part
of consumers’ regular diet as exemplified in the rush of energy bars, meal replacement beverages
and fortified cereals, vitamin/mineral supplements, herbal extracts, etc. The global market for
functional foods is estimated to be over $45 billion in 2002 (Institute of Food Technologists
Functional Foods Newsletter, 2002). Nowadays consumers are more health-conscious and often
search for health foods as part of their daily diets; this drastically alters their consumption and
buying behaviors. Consumers also pay attention to the link between diet and health.
Health benefits from consuming rice bran oil (RBO) have been extensively studied in
humans. RBO has been shown to decrease cholesterol absorption by inhibiting the oxidation of
the LDL-cholesterol. γ-Oryzanol is one of the RBO components that possess antioxidative
properties; it is a polyphenolic compound resembling tocopherol (vitamin E), which is another
component of RBO (Godber et al., 2002).
γ-Oryzanol has not been thoroughly investigated as a functional ingredient in food
products, but its potential applications in human health such as antioxidant activity, reduction of
serum cholesterol, cholesterol absorption as well as of early atherosclerosis risk, inhibition on
platelet aggregation, inhibition of tumor promotion, menopausal syndrome treatment and
antiulcerogenic activity have been thoroughly investigated.
In order to take advantages of the health benefits of γ-Oryzanol, food products fortified or
enriched with γ-Oryzanol should be developed as functional foods that may interest consumers.
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The natural cheese consumption per capita in the U.S. increased almost 2% from 2001 to
2002.

More impressively, during the last quarter of the 20th century, when fluid milk

consumption was rapidly declining, cheese consumption continued to grow. According to the
2003 HealthFocus® Trend Report, use of full-fat cheese is on the rise, but coming at the expense
of low-fat, fat-free, lower-cholesterol and lower-calorie alternatives.
Usual value-added cheese have the addition of herbs, chopped nuts or seeds such as
caraway to the curds of lightly flavored soft cheese. Hard and semi-hard cheeses are, in general,
less suitable for development of value-added variants. Cheddar is the most popular cheese flavor
in North America (Spanier et al., 2001). It is by far the most important variety of hard cheese
and is produced on an extremely large scale and on a world-wide basis (Varman and Sutherland,
2001). In addition, cheddar cheese should be a compatible food matrix with γ-Oryzanol because
it contains the highest amounts of tocopherols (vitamin E) compared with other hard cheeses
which scarcely contain vitamin E (Renner, 1989).
Knowing that cheddar cheese is a very acceptable and well-liked product on a worldwide basis and that it is compatible with the characteristics of γ-Oryzanol, a sharp cheddar
cheese containing γ-Oryzanol was developed in the Dairy Store of the Department of Dairy
Science at Louisiana State University, and the effects of γ-Oryzanol on its quality were studied
during the 5-month ripening process which had not been done before.
The developed cheese was stored for up to 5 months and drawn for quality evaluation
every month. The quality parameters evaluated in the cheese included color, texture, microbial
growth, aroma development, bacterial identification by polymerase chain reaction, oryzanol
retention, moisture content and free fatty acid profile together with consumer acceptance after 5
months of maturation.

2

In this thesis, first, a literature review (Chapter 2) is presented, including background
information related to the topic, such as RBO, health benefits of γ-Oryzanol, cheddar cheese, its
characteristics and manufacturing procedures, functional foods, cheese trends and a brief
discussion of the research justifications. The materials and methods (Chapter 3) are extensively
described with information related to each procedure, including the physicochemical and
biological analyses, the consumer study design and the statistical analysis. The results and
discussion (Chapter 4) of every quality parameter evaluated in this research are presented. The
conclusions are presented in Chapter 5. The last section includes the appendices containing
some figures, the consent form for the consumer study, the questionnaire used for the consumer
study and SAS codes used for the statistical analysis of all experiments.
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CHAPTER 2. LITERATURE REVIEW
2.1 Rice Bran Oil and γ-Oryzanol
Rice Bran Oil (RBO) is made from the pericarp and germ of the Oryza sativa seeds. Rice
bran constitutes about 10% of rough rice grain and contains 18%-22% oil. RBO contains a small
variable quantity of tocotrienols (72-612 ppm, especially β- and γ-tocotrienols) (Rukmini and
Raghuram, 1991; Rogers et al., 1993). Moreover, RBO is naturally very rich in α-tocopherol
(ca. 100 mg), similar to soybean oil, another vegetable oil with a well-known
antihyperlipidaemic action (Changbumrung et al., 1980).
In contrast to most common refined vegetable oils, crude rice bran oil is richer in
unsaponifiable matters such as steryl ferulates which have growth-promoting vitamin-like
activity. Steryl ferulates consist of a mixture of esters of ferulic acid with plant sterol or
triterpene alcohol, which are unique to rice oil, with important pharmacological actions
(Jariwalla, 2001). The prototype member of the group is γ-Oryzanol, which has been extensively
characterized and studied (Naruse and Takeshita, 1999) and was first isolated by Kaneko and
Tsuchiya in the early 1950s (Kaneko and Tsuchiya, 1955).
The most accessible natural source of γ-Oryzanol is rice bran, but some components of γOryzanol, mainly sitostanyl ferulate and campestanyl ferulate and lesser amounts of sitosteryl
ferulate and campesteryl ferulate, can also be found mostly in the inner pericarp of corn, wheat,
rye and triticale grains (Seitz, 1989).
2.1.1 Properties of γ-Oryzanol
γ-Oryzanol is a mixture of ferulic acid esters of triterpene alcohols such as cycloartenol
and 24-methylene cycloartanyl (Figure 2.1), and about 1 to 3% is found in RBO.

4

Its

fundamental molecular structure is the ferulic acid aromatic phenolic nucleus esterified to
cyclopentanperihydrophenanthrene (Seetharamaiah and Prabhakar, 1986).
Gamma-oryzanol is a white or slightly yellowish, tasteless powder with little or no odor
(O’Neil et al., 2001), and its industrial production is shown in the flowchart of Figure 2.2.

Figure 2.1: Oryzanol comprises any of several plant sterols esterified to ferulic acids. The
example shown here is cycloartenyl ferulate.
Raw material: rice bran or rice germ
Extraction
Rice Bran or Rice Germ Oil
Crude Rice Oil
Refining
Refined oil

Soaps
Distillation
Recrystallization
Drying
Sterilization
γ-Oryzanol

Figure 2.2: Production flowchart of gamma-oryzanol.
RBO and its main components are non-toxic and non carcinogenic (Deckere and Korver,
1996), and the γ-Oryzanol molecule may be poorly absorbed after oral administration
(Scavariello and Arellano, 1998). Used commercially in Japan as a food, γ-Oryzanol protects
5

RBO from oxidation and inhibits peroxidation of lipids medicated by iron or UV irradiation. γOryzanol is a polyphenolic compound with hydroxyl groups and resembles tocopherol (vitamin
E) in its antioxidant properties. However, unlike tocopherol, it can increase the antioxidative
ability of rice in a dose-dependent manner, at the same time manifesting resistance to high
temperature (Jariwalla, 2001). Additionally, the antioxidant capacity of γ-Oryzanol is enhanced
in a synergistic manner in the presence of α-tocopherol and other amino acids (Jariwalla, 2001).
2.1.2 Health Benefits of γ-Oryzanol
One of the most investigated properties of γ-Oryzanol is its antiulcerogenic property
(Mizuta et al., 1978; Ichimaru et al., 1984). Different studies have been carried out on rat
models to evaluate which pharmacological mechanism is mainly involved in γ-Oryzanols'
antiulcerogenic property. One study investigated the antiulcerogenic effect of γ-Oryzanol in
mice subjected to conditioned emotional stimuli (communication box method) and rapid eye
movement (REM) sleep deprivations (flower pot method). The incidence of gastric lesions was
reduced by a single administration of γ-Oryzanol at 100 and 200 mg/kg.
γ-Oryzanol has also found an application as a medical antioxidant when used in
combination with α-tocopherol.

Although γ-Oryzanol is widely employed in the cosmetic

industry as an antioxidant, only one scientific study is available in the literature concerning its
modulating effect on sebaceous gland secretion after the topical application (Ueda et al., 1976).
Moreover, γ-Oryzanol is widely employed as an anabolic agent by bodybuilding athletes
(Rosenbloom et al., 1992; Grunewald and Bailey, 1993).
When γ-Oryzanol (300mg/day) was administered for 3 months to hyperlipidaemic
subjects, a significant decrease in plasma level of total cholesterol (TC) and low density
lipoprotein

cholesterol

(LDL-C)

was

observed
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in

both

hypercholesterolaemic

and

hypertriglyceridaemic patients, while a relevant increase in high density lipoprotein cholesterol
(HDL-C) was observed only in the hypercholesterolaemic group, and no side effects were
observed (Raghuram et al., 1989; Cicero and Gaddi, 2001; Yoshino et al., 1989a; 1989b).
Similar results were obtained when chronic schizophrenic patients with dyslipidaemic who had
been receiving neuroleptics for a mean of 10 years were treated with 100 mg of γ-Oryzanol three
times daily for 16 weeks (Sasaki et al., 1990), and also when postmenopausal women having a
diet enriched with test oils having γ-Oryzanol (Lichtenstein et al., 1994).
A decrease in early atherosclerosis and reduction of cholesterol absorption were
observed by Rong et al. (1997). Research investigating the influence of oryzanol on platelet
aggregation in rats concluded that oryzanol inhibited the aggregation (Seetharamaiah et al.,
1990).
Nair et al. (1984) concluded that RBO and γ-Oryzanol contribute to lowering the risk for
colon cancer in humans. Yasukawa et al. (1998) reported that γ-Oryzanol and its four major
components (cycloartenyl ferulate, 24-methylene cycloartanyl ferulate, campesteryl ferulate and
sitosteryl ferulate) had an inhibitory effect on tumor in two-staged carcinogenesis in mouse skin.
In similar studies, the modifying effects of phytic acid and γ-Oryzanol on the promotion stage of
carcinogenesis were investigated using several two-stage carcinogenesis models in rats. The
female rats were pretreated with a single intragastric dose of 7,12-dimethylbenz(a)anthracene
(DMBA). There were no significant differences in the final incidences and multiplicities of
mammary tumors; the average tumor diameter was significantly reduced, and the average
survival time was increased with phytic acid and γ-Oryzanol but without significant difference
(Hirose et al., 1999). These results indicate that phytic acid inhibits hepatic and mammary
carcinogenesis.
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A water-soluble oryzanol enzymatic extract (WSOEE) was developed recently and
evaluated for its antioxidant potential. WSOEE has been shown to have the in vitro antioxidant
capacity due to the extensive scavenging of peroxyl radicals.

WSOEE is a new potential

antioxidant agent from rice bran, being a new source of water-soluble oryzanol. This soluble
product showed a high free-radical-scavenging capacity, preventing protein oxidation and lipid
peroxidation when cells ex vivo were exposed to active-oxygen substances and/or free radicals.
This property makes it potentially useful in the formulation of solid and liquid food for treatment
and prevention of chronic pathological states associated with a high generation of active-oxygen
substances and/or free radicals – such as atherosclerosis, neurodegeneration, and cancer – and for
elderly persons and practitioners of sports (Parrado et al., 2003).
The effect of high oryzanol RBO on the oxidative stability of low-heat and high-heat
whole milk powder (WMP) was investigated by Nanua et al., 2000. The results from this study
indicated that RBO has potential for use as a natural antioxidant in WMP, due to the presence of
tocopherols and tocotrienols as part of the unsaponifiable matter, which have well-studied
antioxidative properties.
Antioxidant activities of vitamin E and γ-Oryzanol components purified from rice bran
were

studied

in

a

cholesterol

oxidation

system

accelerated

by

2,2’-azobis(2-

methylpropionamidine) dihydrochloride, and all components exhibited significant antioxidant
activity in the inhibition of cholesterol oxidation (Xu et al., 2001).
2.1.3 Applications of γ-Oryzanol
γ-Oryzanol has suggested to have potential functionality such as antioxidant activity,
reduction of serum cholesterol, reduction of cholesterol absorption and decrease of early
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atherosclerosis, inhibition on platelet aggregation, inhibition of tumor promotion, menopausal
syndrome treatment and antiulcerogenic activity.
Since the functionality of γ-Oryzanol is promising, rice bran or γ-Oryzanol may have
great market potential and can be applied to a wide range of products and functional foods that
may provide cholesterol-lowering and antioxidant effects.
2.2 Cheese
The word “cheese” is commonly used as a collective term for widely variable products
such as matured and non-matured cheese made with rennet, acid curd cheese, fresh cheese, and
even processed cheese. Most of these fit the definition established by the FAO/WHO, i.e.,
cheese is the fresh or matured solid or semi-solid product obtained by coagulating milk,
skimmed milk, partly skimmed milk, cream, whey cream, or buttermilk, or any combination of
these materials, through the action of rennet or other suitable coagulation agents, and by partially
draining the whey resulting from such coagulation.
2.2.1 Cheese Principles
Cheese manufacturing is aimed at making an attractive and durable product in which
important nutrients of the milk are concentrated. The cheese must be left to ripen to acquire
desirable flavor and consistency. To achieve this, cheese is kept for a variable time under
favorable conditions. Cheese making is a complicated process, involving many processing steps
and several biochemical transformations. All of these variables affect yield, composition, and
quality of the cheese and its byproducts (predominantly whey), and often in different directions
(Walstra et al., 1999).
When milk is made into cheese, casein and fat are concentrated, whereas the other milk
components, especially water, are mainly removed along with whey.
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None of the milk

components are fully retained, and other substances may be added, notably salt.

This is

illustrated in Figure 2.3. The yield and the composition of the cheese are determined by the
properties of the milk, especially composition, and by the manufacturing practice.

Figure 2.3: Example of the gross composition of milk and cheese and of the transfer of
components from milk to cheese (Walstra et al., 1999).
The manufacture of cheese may involve many different processing steps, where some
steps are essential for all cheese varieties: (1) clotting of the milk by means of enzymes or acid,
or both (a gel is formed, due to the casein particles aggregating into a network, enclosing fat
globules), (2) removal of whey (comparable to milk serum) by means of syneresis of the gel (the
resulting curd makes up 10% to 30% of the original volume of milk; the drier the curd, the firmer
10

and the more durable the cheese will be), (3) acid production in the cheese during its
manufacture due to the conversion of lactose into lactic acid by lactic acid bacteria (the resulting
pH of curd and cheese affects such parameters as syneresis, consistency, and ripening of the
cheese), (4) salting, (5) fusion of curd grains into a coherent loaf that is easy to handle, and (6)
ripening (microbial, biochemical, chemical, and physical processes during ripening are
responsible for changes in composition and structure of the cheese; hence flavor and texture).
Fusion of curd grains and ripening are typical processing steps of ripened cheese; when
these are not carried out, the product is referred to as fresh cheese (Walstra et al., 1999).
With the objective of diminishing variation in the course of the manufacture of the cheese
and in its properties, some additional process steps have been applied: pasteurization of the milk
and addition of cultures of microorganisms to the milk.
By using different biochemical processes, the relatively tasteless dairy protein is
converted into tasty and easily digestible cheese with different flavors.

Cheese is rich in

essential amino acids and it also binds large amounts of minerals and vitamins (Spreer and Mixa,
1998).
Worldwide, there are more than 2000 types of cheese, sometimes made by very different
manufacturing processes. A classification can be based on several aspects, and is done in
different countries according to different criteria. A general classification can be made for three
major groups: rennet or natural cheese, fresh cheese or non ripened cheese and long-life cheese
(processed cheese). For another classification into groups and types, different aspects and
characteristics can be used, such as: type of process (rennet cheese, rennet acid cheese, acid curd
cheese, processed cheese), type of consistency (hard, semi hard, semi soft, soft cheese), type of
milk (cow, sheep, goat, buffalo), chemical composition (Calcium content in conjunction with
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pH, dry matter, water, fat), ripening process (ripened cheese and non ripened/fresh cheese),
variations in taste, type of hole formation (large, medium and small round holes, cracks, irregular
holes, no holes) and surface characteristics (blue fungus or white fungus cheese, smear cheese,
skinless cheese). A general and internationally recognized classification is based on the raw
material, type of consistency, interior and exterior, interior hole formation and surface
characteristics (Spreer and Mixa, 1998).
2.2.2 Cheddar Cheese Properties
Cheddar-type cheeses are characterized by the mixing of salt with the curd before
pressing it into a coherent loaf. Salt considerably retards the growth of lactic acid bacteria.
Because of this, most of the lactose in the curd should have been converted before the curd is
salted. Moreover, salted curd tends to fuse poorly during pressing if its pH is still too high
because the curd flows insufficiently (Walstra et al., 1999).
Cheddar cheese is classified as a hard cheese, with a long shelf life and without a surface
flora. It is about 45% to 50% fat in the dry matter and minimum dry matter of 62% (Spreer and
Mixa, 1998). It has a buttery but firm body with close texture and a clean nutty flavor (Varnam
and Sutherland, 2001).
Cheddar cheese contains little active milk proteinase, active rennet, and a large pool of
proteolytic enzymes from lactic acid bacteria; most of the fast acid-producing strains are also
strongly proteolytic. At the low curing temperature (usually below 10°C) the proteolysis in the
depth is relatively slow, whereas the degradation in the width is fast. It may be cured for varying
lengths of time, from 3 to 15 months (Early, 1992). The curing room is around 85% percent
relative humidity at 4°C (40°F) and the cheese is held for 60 days or longer. The peak flavor is
usually attained in 9 to 12 months (Kosikowski and Mistry, 1997).
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Defects that may occur in Cheddar cheese include: open texture which may lead to
formation of cracks upon gas production during maturation, “seaminess” which refers to the
appearance of whitish “veins” seen in a cross-section of the cheese, incomplete acid production
that often is responsible for insufficient flavor and abnormal consistency, contaminating bacteria
that may cause defects, especially at high pH, low salt content, and high ripening temperature,
difficulties in cooling down the interior of the cheese when made in very large blocks, and bitter
flavor development if the salt content is low and the curing temperature is high (Walstra et al.,
1999).
2.2.3 Cheddar Cheese Manufacture
A big demand is put on the starter culture. The curd making should be as brief as
possible for economical reasons, and this requires very fast acid production. Therefore, fastgrowing, fast acid-producing and phage-resistant bacteria are needed. This combination is hard
to fulfill; for that reason, mixtures of single-strain, fat starters are generally employed, and
contamination of the starter by phages is rigorously prevented. Furthermore, the starter should
be homofermentative (little gas production), and cause no bitterness in the cheese. Strains of
Lactococcus lactis var. cremoris are usually used.

Currently, a mixture of two strains

(Lactococcus lactis subsp. cremoris and subsp. lactis) is often applied, e.g., in a ratio of 1:2
(Walstra et al., 1999). The former strain is fairly heat-tolerant (i.e., it keeps growing during
scalding) and is responsible for a fast acid production; however, these bacteria form many bitter
peptides which are decomposed poorly. The second strain is far less heat-tolerant (it does
produce some acid during scalding, but it does not keep growing, and hence contributes little to
the rate and extent of acid production), but has considerable “debittering” properties while not
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producing many bitter peptides itself; hence, the proteolytic system of these bacteria is of great
importance for a satisfactory maturation (Walstra et al., 1999).
Figure 2.4 outlines the manufacturing process of cheddar cheese.

It represents a

somewhat traditional way of manufacturing, although formerly the time from renneting to
milling often was even much longer. Nowadays a fixed time schedule is usually maintained and
the processing time is much shorter, e.g., 3 hours from renneting to milling.
After cutting, stirring and scalding, the curd settles and fuses into a rather compact mass.
Then “cheddaring” starts, which is a process, characteristic of Cheddar and of most of its related
types. The whey is drained off, and the curd mass cut into large strips that are piled up. The
slabs fuse again and are allowed to spread slowly into thinner slabs that are turned, cut again into
strips, piled up, etc.
The curd mass will only flow readily if its pH is lower than 5.8 and the temperature is not
too low. The flow causes a “fibrous” curd structure. It has long been assumed to be essential for
obtaining a characteristic Cheddar.
Paramount is the acid production during cheddaring. The water content and pH of the
curd at that stage largely determine the composition of the cheese. The curd is pressed into a
loaf when its acidity is low.
Prior to salting, the curd is milled, i.e., cut into strips about the size of a finger. Milling
too finely leads to excessive loss of fat and curd fines in the press whey. Milling too coarsely
causes a longer time for the diffusion of the salt into the strips to complete, resulting in a non
homogeneous cheese texture. The salt is mixed with the curd and some time is allowed for salt
absorption (mellowing); otherwise, excessive salt would be lost with the whey, which in normal
cases already contains about 50% of the added salt (both milling and pressing cause a
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considerable expulsion of whey). The salt should be evenly distributed, but this is hard to
achieve. Acid production in the curd is insufficient if the cheese contains over 5% to 5.5% salt
in the water, while at less than 4.5% salt the lactic acid bacteria ferment too fast. In either case
the flavor development is unsatisfactory and contaminating organisms have a greater chance of
growing out, which may cause strong off-flavors (Walstra et al., 1999).

Figure 2.4: An example of a traditional method for manufacture of Cheddar cheese. Simplified
from Walstra et al. (1999).
15

The curd, after salting, is usually pressed under vacuum and lower pressure. The lower
the temperature and the pH during pressing, the more difficult it is to transform the salted curd
into a coherent loaf.

Soon after pressing, the cheese (often in the shape of large blocks) is

supplied with a surface coating (e.g., paraffin), after which it needs little further care; but it is
also common to find processors making rindless cheddar cheese (Kosikowski and Mistry, 1997).
2.3 Functional Foods
2.3.1 Definitions
Japan is the birthplace of the term “functional foods”. The term “Foods for Specific
Health Use (FOSHU)” was established in 1991 after large-scale research programs were
launched and funded by the Japanese government in the early 1980s on systematic analysis and
development of food functions, analysis of physiological regulation of the function of food and
analysis of functional foods and molecular design (Ashwell, 2002). Afterwards, a variety of
terms, more or less related to FOSHU have appeared world-wide. These include more exotic
terms, such as nutraceuticals, designer foods, pharmafoods, medifoods, vitafoods and the more
traditional dietary supplements and fortified foods. All are foods or food products marketed with
the message of a benefit to health.
The term “nutraceutical” was coined from “nutrition” and “pharmaceutical” by Stephen
DeFelice, founder of Foundation for Innovation in Medicine, in 1989. He defined a nutraceutical
as a food, dietary supplement, or medical food that has a medical or health benefit, including the
prevention and treatment of disease (DeFelice, 1995).
For FDA, functional foods can fall into a number of existing categories of the Federal
Food, Drug and Cosmetic Act of 1938 (FDCA), as amended. If the product is determined to be a
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food and not a drug, it can be regulated as conventional food (including food for special dietary
use), dietary supplements, medical food, or as infant formulas.
In Canada, two definitions emerged. A nutraceutical is a product isolated or purified
from foods that is generally sold in medicinal forms not usually associated with food. A
nutraceutical is demonstrated to have a physiological benefit or provide protection against
chronic diseases. A functional food is similar in appearance to, or may be, a conventional food,
is consumed as part of a usual diet, and is demonstrated to have physiological benefits and/or
reduce the risk of chronic disease beyond basic nutritional functions (Dentali, 2002).
The European Commission (EC) Concerted Action known as FUFOSE (Functional Food
Science in Europe) states that a food can be regarded as functional if it is satisfactorily
demonstrated to affect beneficially one or more target functions in the body, beyond adequate
nutritional effects, in a way that is relevant to either an improved state of health and well-being
and/or reduction of risk of disease.

Functional foods must remain foods, and they must

demonstrate their effects in amounts that can normally be expected to be consumed in the diet.
They are not pills or capsules, but part of a normal food pattern (Ashwell, 2002).
Since 1989, the nutraceutical or functional food industry has evolved into a market worth
$20.2 billion in the U.S. and a global market estimated to be $47.6 billion in 2002 (Institute of
Food Technologists Functional Foods Newsletter, 2002).
According to a Business Communications Co., Inc. report, the nutraceuticals market’s
growth is attributed to different factors: consumers have an increasing interest in maintaining
better health, there has been a rise in available information regarding the link between diet and
health, many consumers wish to avoid spending money on health care and prescription
medications, there have been several changes in food laws that have affected label and product
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claims and an increasing sector of the public is quickly aging and purchasing functional food
products (Business Communications Co., Inc., 2003). This report clearly shows that there is a
real gap to introduce more functional foods in the U.S. market, and consumers will be interested
in them.
2.3.2 Cheese Trends
The growing importance of health and wellness has significantly altered consumption and
buying behaviors. Low-carbs diets, concerns about trans-fat and obesity, and greater demand for
organic and natural products are requiring a shift in what it is marketed and how it is marketed.
The consumer demand for convenience has always been a driving factor in the food industry.
But as the pace of life quickens, consumer expectations continue to rise, whether it’s for ease of
preparation, greater portability or the convenience of single-serve packages.
Consumers learned during the 1990s that, for the most part, to enjoy cheese they could
not cut back on fat grams. In fact, when most consumers choose cheese, they are not too worried
about the Nutrition Facts label, the emphasis is on flavor (Berry, 2004).
The natural cheese consumption per capita in the U.S. increased almost 2% from 2001 to
2002.

More impressively, during the last quarter of the 20th century, when fluid milk

consumption was rapidly declining, cheese consumption continued to grow. In fact, since 1980,
consumption of natural cheese per capita has increased roughly 75% (USDA/ERS, 2003) and
about 60% for cheddar cheese (USDA/ERS, 2004).
According to the 2003 HealthFocus® Trend Report, use of full-fat cheese is on the rise,
but coming at the expense of low-fat, fat-free, lower-cholesterol and lower-calorie alternatives.
In 2002, only 26% of shoppers used low-fat, low-cholesterol or low-calorie cheese weekly, down
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19 points from 45% in 1994. Use of regular or full-fat cheese was 61%, up 8 points from 53% in
1994. Use of fat-free cheese, which has only been tracked since 2000, was down 2 points.
Cheesemakers continue to be innovative in the range of flavors added to cheese. They
are taking natural cheese favorites and giving them exciting new flavor profiles, Havarti, for
instance, is now available with horseradish and chives, Cheddar is spiked with Pinot Grigio or
Shiraz, and Smoked Gouda is enhanced with garlic (Berry, 2004). Convenience is another trend
that continues on an upward trajectory.
Cheddar and Hispanic-style cheeses are the most preferred cheeses on burritos and
quesadillas, with almost three-fourths of all consumers preferring multiple cheeses on these
Mexican foods. Indeed, the popularity of Hispanic foods, along with Hispanic cheeses, is at an
all-time high. Manchego, asadero, queso blanco, all Hispanic cheeses, promise to become as
familiar to the U.S. consumer as Cheddar and Mozzarella.
Though still a relatively small niche, organic dairy products, including cheeses, are
among the fastest growing food categories. Consumer demand for products perceived to be
healthful and natural is fueling the trend, as is cheesemaker and dairy producer interest in reaping
the often significantly higher margins that organic products command.
Vitamin D is important in human bone health. Leading public health experts are getting
concerned that the general population is not getting enough vitamin D as a result of decreased
consumption of milk and increased used of sunblock (the body makes vitamin D when
unprotected skin is exposed to sunlight). Researchers at the Minnesota-South Dakota Dairy
Foods Research Center, St. Paul, Minn., have successfully fortified pasteurized processed cheese
with vitamin D3 (100 IU per serving). There was no loss of vitamin D3 during manufacturing,
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and the vitamin was uniformly distributed. No loss of the vitamin occurred during storage over a
nine-month period (Lovette, 2004).
Recent media attention surrounding cholesterol created a new market for dairy products
that work to reduce the level of low-density lipoproteins (LDL) levels found in the body.
Glanbia Dairies (Dublin, Ireland) introduced an innovative product in the United Kingdom called
Heartily Healthy cholesterol-reducing cheese alternative.

Since cheese products typically

contain high levels of cholesterol, the company states that the Cheddar-style product is made
using milk that has had the dairy fat replaced with wheat germ oil-–an ingredient known to
combat cholesterol (Kuhn, 2004).
2.4 Research Justifications
γ-Oryzanol utilization, as a functional ingredient, has not been thoroughly investigated.
Its potential applications in human health such as antioxidant activity, reduction of serum
cholesterol, cholesterol absorption and risk of early atherosclerosis, inhibition on platelet
aggregation, inhibition of tumor promotion, menopausal syndrome treatment and antiulcerogenic
activity, are excellent reasons to take advantage of the health benefits of γ-Oryzanol
consumption. In order to take advantage of these benefits, food products fortified or enriched
with γ-Oryzanol should be developed as functional foods that may interest consumers.
In order to find the best food product fitting the potential functionalities of γ-Oryzanol, its
properties must be taken into account. γ-Oryzanol is liposoluble, and its antioxidant activity is
enhanced synergistically in the presence of α-tocopherol as described in section 2.1.1.
A product which delights the taste of a big percentage of the population and is healthy by
itself is a good potential target, regardless of race, religion, background or social stratus. Hard
cheeses contain high amounts of fat, are an excellent source of Calcium for lactose intolerant
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people, and also contain proteins with essential aminoacids necessary for a normal body
metabolism. Hard cheeses also contain microorganisms which benefit human intestinal flora.
Adding a nutritive value to a hard cheese with health benefits creates consumer awareness of the
functional cheese products.
Several studies suggest that dairy foods such as cheese and milk prevent demineralization
of enamel and favor remineralization related with dental caries. Silva et al. (1986) using
intraoral caries models (i.e., models that use sections of human or bovine enamel placed at
interproximal sites in fixed appliances), found that consumption of 5 g of aged Cheddar cheese
immediately following sucrose intake (i.e., a 10 percent sucrose challenge) reduced, by an
average of 71%, sucrose-induced demineralization of experimental enamel slabs. Likewise,
using a new in situ caries model developed by Featherstone and Zero (1992), enamel
demineralization occurred in the absence of Cheddar cheese. In contrast, in the presence of
cheese, a significant trend toward remineralization of enamel was evident.

In addition,

components in cheese or milk such as protein (casein and whey), lipids, calcium, and phosphorus
may be partly responsible for the beneficial effects of these foods on oral health (Miller et al.,
1995).
Cheddar is the most popular cheese flavor in North America (Spanier et al., 2001); it is
by far the most important variety of hard cheese and is produced on an extremely large-scale and
on a world-wide basis (Varnam and Sutherland, 2001). In addition, cheddar cheese shows a
compatible food matrix with γ-Oryzanol because it contains the highest amount of tocopherols
(vitamin E) compared to other hard cheeses which scarcely contain vitamin E (Renner, 1989),
and thus its antioxidant effects can be enhanced.
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In a search performed in Medline (PubMed), in Agricola and in Ingenta with key words
combining “rice bran oil”, “RBO”, “oryzanol”, “gamma-oryzanol”, “γ-oryzanol”, “nutraceutical”
or “functional” with “cheese”, it could be noticed that there has not been any research on cheese
containing RBO components or γ-Oryzanol, nor or the possible effects of these compounds in
the quality of the cheese.
Usually value-added cheeses have had the addition of herbs, chopped nuts or seeds such
as caraway to the curds of lightly flavored soft cheese. Hard and semi-hard cheeses are, in
general, less suitable for development of value-added variants. Cheddar cheese and related
cheeses, may, however, be supplemented with various materials including chopped walnuts and
pickles. Both hard and soft types are involved and may be blended with a range of beverages
including beer, whisky, port wine and liqueurs (Varnam and Sutherland, 2001). Nutritionally
modified cheeses are mostly related with low-fat soft cheese varieties or hard cheeses using
unmodified technology which lacks of the characteristic ripened flavor of the full fat equivalent
and has bitter taste characteristics.
With one in four Americans suffering from some form of coronary heart disease, 108
million with high cholesterol levels, it is not surprising that almost every consumer behavior
related to improving heart health has escalated (AHA, 2004). Four out of ten of households
(43%) are treating a member for high cholesterol (Sloan, 2004) and with 44% of shoppers saying
that reducing the risk of heart disease or helping to maintain healthy cholesterol levels is an
extremely/very important food claim.

Marketers have begun differentiating heart-healthy

products based on their ingredients (HealthFocus®, 2003).
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For all the reasons mentioned above, cheddar cheese containing γ-Oryzanol was
developed, which could potentially have better positive effects in humans than other products
with a different nutritional profile.
2.5 Objectives
2.5.1 General
The main goal of this study was to develop a sharp cheddar cheese containing γ-Oryzanol
and study its effects on cheese quality during and after the ripening process.
2.5.2 Specific
Determine quality differences of sharp cheddar cheese containing γ-Oryzanol by
evaluating color, texture, microbial growth, aroma development, moisture content, free fatty acid
profile, starter culture performance and the oryzanol retention together with a consumer study
after 5 months of maturation.
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CHAPTER 3. MATERIALS AND METHODS
3.1 Cheddar Cheese Manufacturing
The process used to produce the cheddar cheese containing γ-Oryzanol was similar to the
method shown in Figure 2.4 (section 2.2.3).
The facilities of the creamery in the Dairy Science department in the LSU campus were
used to produce the cheddar cheese containing γ-Oryzanol.
Milk obtained from the LSU farm (6201 Lb) was pasteurized on October 28th, 2003 at
177°F (77°C) for 20 seconds, then kept overnight below 40°F (4.5°C) until the next day for the
cheese making. The milk contained 3.46% of fat and 3.06 % of protein.
On October 29th, 2003, early in the morning, the pasteurized milk was poured in a vat and
heated slowly with constant stirring. The heating process was continued by increasing the
temperature at a rate of 1°F every 2 minutes for approximately 1.5 hours until the temperature
reached 88°F (Figures 3.1 and 3.2).
At this point, the starter culture, mesophilic direct vat set (DVS) from CHR Hansen
(Milwaukee, WI) was added at 2.1% by weight (Figures 3.3 and 3.4), which contains selected
strains of Lactococcus lactis subsp. cremoris and subsp. lactis. Together with the starter culture,
the color (annatto food color) was added, at 0.03% by weight (Figures 3.5 and 3.6).
The milk with the starter culture and the color was stirred at 88°F for 45 minutes.
Immediately afterward, calcium chloride food-grade (CaCl2 aqueous solution 32%) from DSM
(DSM Food Specialties, Menomonee Falls, WI) was added at 0.02% w/v (Figure 3.7).
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Figure 3.1: Stirring milk in the vat while being heated up.

Figure 3.2: Stirring milk in the vat while being heated up before adding culture.
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Figure 3.3: Adding starter culture to milk when temperature reached 88°F.

Figure 3.4: Different view of the addition of the starter culture to the heated milk.
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Figure 3.5: Adding color to heated milk after starter culture was added.

Figure 3.6: Color added to heated milk while stirring.
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Figure 3.7: Addition of CaCl2 to the milk after the culture and color were added.

Figure 3.8: Adding the rennet into the milk after the culture, color and CaCl2 were added.
The process continued with agitation at 88°F for 15 minutes then the rennet from CHR
Hansen (Milwaukee, WI) was added at 0.01% with a dilution 1/50 in water.

The rennet

consisted of a 100% fermentation produced chymosin, Sodium Chloride (NaCl), Sodium
Benzoate and caramel color. The addition of CaCl2 and rennet is shown in the Figures 3.7 and
28

3.8, respectively. The stirring was continued for a few seconds just to mix the rennet, then the
agitation was stopped, and the milk was allowed to settle down for 35 minutes as the renneting
took place. Figure 3.9 shows that the vat was covered while the renneting process took place.
After 35 minutes, the hardness of the curd formed from the renneting process was
checked to see if it was hard enough to start cutting (Figure 3.10). As soon as the curds’
hardness was desirable, all the curd was cut as shown in Figures 3.11 and 3.12 and then was
allowed to heal for 5 minutes. The cutting process was done with extreme carefulness to avoid
destroying the curd cubes since they are still fragile and soft.

Figure 3.9: Renneting taking place in the vat while the temperature was still 88°F.
Healing the curd can be observed in the Figure 3.13 where the curd was left undisturbed
without agitation, and the cooking of the curd is shown in the Figure 3.14 when agitation was
started again.
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The cooking process is also referred to as scalding which involves an increase of
temperature from 88°F to 102°F at a rate of 3°F every five minutes with constant agitation. The
temperature was held at 102°F for about one hour.

Figure 3.10: Cutting the curd as a pre-test to check if it was hard enough to continue the
process.

Figure 3.11: Cutting the curd after renneting.
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Figure 3.12: Another view of the process of cutting the curd after renneting.

Figure 3.13: The curd is healed by letting it sit without stirring.
After letting the curd sediment to complete, the whey protein was drained out of the vat
(Figures 3.15 and 3.16) while keeping the curd in the vat as shown in Figure 3.17.
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Figure 3.14: Cooking the curd with agitation and increasing the temperature.
To allow the whey protein to come out of the curd, the curd was cut in loaves (Figure
3.18). Then the loaves were separated as shown in Figure 3.19 and flipped over every 15
minutes to facilitate the separation of the whey protein from the curd.

Figure 3.15: Draining of whey proteins out of the vat.
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Figure 3.16: Draining of whey protein, while keeping the curd inside vat.

Figure 3.17: Draining of whey protein, while keeping the curd inside vat (continued).
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Figure 3.18: Cutting curd into loaves of 20 inch long and 10 inch wide.

Figure 3.19: Flipping loaves over to help drain whey protein out of the curd.
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Figure 3.20: Two loaves of curd stacked to help release of whey protein in vat.
Stacking loaves over loaves increases pressure to release the whey protein still trapped in
the curd, and flipping over also helps to drain whey protein. Turning the loaves up side down
took about 1.5 hours.
The temperature of the vat was still kept at 88°F. Once the titrable acidity reached
0.45%, the loaves were no longer flipped over and subsequently were milled in pieces of
approximately one inch by one inch by two to three inches (Figure 3.22).
Once all the loaves were milled and spread over the surface of the vat, the curd was
allowed to rest for 15 minutes, then salt was added at 2.8% w/w in 3 additions every 10 minutes
and mixed (Figure 3.23).
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Figure 3.21: Four loaves of curd stacked to help release of whey protein in vat.

Figure 3.22: Milling the curd loaves into smaller pieces (1x1x2-3 inches).
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Figure 3.23: Mixing salt with the milled curd which lasted approximately 30 minutes.
At this point, a part of the salted curd was separated from the rest and the γ-Oryzanol
(Maypro Industries, Inc., Purchase, NY) of 98.8% purity was added in amount to attain a
concentration of 100mg per 28 grams of curd (see Appendix E for certificate of analysis of γOryzanol). The mixing of γ-Oryzanol was done manually. The salted curd without γ-Oryzanol
was used as the control.
The curd was allowed to rest for about 10 minutes and then filled into a hoop of 40
pounds having cheesecloth wrapped to avoid loss of curd during subsequent pressing (Figure
3.24).
In the Figure 3.25, the pressing process using a pneumatic method can be seen where the
curd was pressed and left overnight under a pressure of 50 psi.
Following the overnight pressing step, the pressed curd was taken out of the hoops,
separated from the cheesecloth and vacuum packed in plastic bags (Figure 3.26). The plain curd
(the control sample) and the curd containing γ-Oryzanol were packed separately. After the curd
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was packed in vacuum in plastic bags, the cheese is ready to be maturated in cold humid rooms
for up to 5 months.

Figure 3.24: 40 pound hoops with cheesecloth wrapping the salted curd.

Figure 3.25: Hoops filled with the curd pressed under 50 psi pressure overnight.
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Figure 3.26: Vacuum packed curd ready to be maturated.
3.2 Cheese Ripening
The ripening process allows flavor, texture and aroma to develop. For the cheddar
cheese, an appropriate storage condition would be relative air humidity (RH) between 75% and
80%, temperatures between 5°C and 16°C, and ripening time for 150 days (Walstra et al., 1999).

Figure 3.27: Storage of the cheddar cheese in the Dairy Store at LSU.
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Our cheese products were stored in the cooler at 40°F (4.4°C) and RH of 85% for up to 5 months
(Figure 3.27). Prior to storage, the cheese was packed in labeled small plastic bags after being
cut to small pieces to facilitate the sampling for subsequent experiments and to avoid confusion.
3.3 Samples and Sampling
The cheddar cheese samples consisted of one control which was the normal sharp
cheddar cheese and one treatment of cheddar cheese with γ-Oryzanol targeting 100mg per
serving size (28g). Two batches of cheeses were collected for this experiments.
Monthly sampling up to three months was performed during ripening in order to measure
different aspects of the quality of the cheddar cheese. The cheese was separated in different bags
for different analyses (Figures 3.28 and 3.29).

Figure 3.28: Cheese separated in small bags for different analyses.
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Figure 3.29: Cheese packed in vacuum in small bags for different analyses.
3.4 Analysis
Different analyses were performed for both treatment and control to determine
differences in the quality of cheddar cheese containing γ-Oryzanol such as: color, texture,
microbial growth, aroma development, bacterial identification by polymerase chain reaction
(PCR), oryzanol retention, moisture content, free fatty acid profile and at the end of maturation, a
consumer study.
3.4.1 Color
The color spectrum is a combination of different parameters which are visualized in
Figure 3.30, where L* is lightness, a* is redness and b* is yellowness.
In a 2 dimension form, the color spectrum can be seen in Figure 3.31, where a* and b*
were defined above and the hue angle (H°) equals tan-1 (b*/a*).
The L*, a* and b* parameters express the color on the basis of luminance, which is the
descriptor of color not visible to human eyes. a* and b* are chroma coordinates, c* is the
derived quantities saturation (chroma) defined as a right triangle (a*2+b*2)1/2. L* may have
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values between 0 and 100, a* and b* may have values between around -80 and +80 (BergerSchunn, 1994) but usually are between -60 and +60. The negative values of a* and b* show the
greenness and blueness of the sample, respectively.
The vocabulary used for color analysis is the internationally accepted nomenclature of the
CIE (Commission Internacionale de l’Eclairage; International Commission on Illumination).
The L*, a*, b* (CIELAB) color space and the color differences (∆E) that result from this
color space are described with the following equation (coordinates from standardized color
spaces and the resulting color differences are marked with an asterisk):
∆E* = [(∆L*)2 + (∆a*)2 + (∆b*)2]1/2

Figure 3.30: 3-D color spectrum.
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The ∆E* is the distance between two samples in a visual uniform color space
corresponding to the color difference between the two samples. (∆ is the mathematical symbol
for difference). In the calculation of color difference, ∆E, with the help of all color difference
formulas, the values of the standard always are subtracted from the values of the sample.
The color of the cheese was measured with a spectrophotometer Minolta model CM-508d
Series (Osaka, Japan) with a 10° standard observer and D65 illuminant.

The following

parameters were recorded from the machine: L*, a*, b*, c* and H°. The spectrophotometer was
calibrated to white with a standard supplied by the company each time a different replication was
analyzed.

Figure 3.31: 2-D color spectrum.
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Cheese was cut in cubes of 2cm by 2cm, allowed to cool down to room temperature and
then color-measured by the spectrophotometer. Twelve different cubes were analyzed for each
replication of each sample.
3.4.2 Texture
Texture profile analysis (TPA) imitates the grinding action of the jaw; it is performed by
subjecting a specimen to a two-step compression. The first compression step, known as the “first
bite”, is followed by a second compression, the “second bite” (Figure 3.32). This is to simulate
the first two bites taken during chewing of the food (Gunasekaran and Mehmet, 2002). The two
compression steps may be separated by an optional wait time.

Figure 3.32: Two bite compression test as performed in a typical texture profile analysis
(www.texturetechnologies.com/texture_profile_analysis.html).
A typical TPA test performed using a UTM (Universal Testing Machines) would
generate a force-time profile as shown in Figure 3.33.
The many textural parameters determined from the TPA force-time (or deformation)
curve are: hardness, cohesiveness, adhesiveness, chewiness, gumminess, springiness, and
fracturability.
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Figure 3.33: Schematic of a typical two-bite texture profile analysis force-time curve
(www.texturetechnologies.com/texture_profile_analysis.html).
Hardness (N) is the force necessary to attain a given deformation. Fracturability (N) is
the force at significant break in the curve on the first bite (originally known as “brittleness”).
Cohesiveness (no units) is the strength of the internal bonds making up the body of the product
(it can be Area 2/Area 1 or also Area 6/Area 4 from Figure 3.33). Adhesiveness (J) is the work
necessary to overcome the attractive forces between the surface of the food and the surface of
other materials with which the food comes in to contact. Gumminess (N) is the energy needed to
disintegrate a semisolid food until it is ready for swallowing. Chewiness (J) is the energy needed
to chew a solid food until it is ready for swallowing. Springiness (m) is the distance recovered
by the sample during the time between the end of first bite and the start of second bite (originally
known as “elasticity” – rate at which a deformed material goes back to its undeformed condition
after the deforming force is removed). Resilience (no units) is the measure of how well a
product “fights to regain its original position” (Gunasekaran and Mehmet, 2002).
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For the TPA of the cheddar cheese, gumminess is not used since cheese is a solid and not
a semisolid even that gumminess may be a better term than chewiness for cheese and other
semisolid foods (Lee et al., 1978). Also, for most cheeses and other soft foods, fracturability is
either unidentifiable or not meaningful (Gunasekaran and Mehmet, 2002).
The TPA of the cheese was done with a texture analyzer Stable Micro Systems model
TA.XT.plus (Texture Technologies Corp., New York) using a cylindrical probe TA-30
compression platen having a diameter of 3 inches and a TA-90A flat plate with a TA-90 heavy
duty platform. A calibration of height and weight was performed every day the machine was
used with the following values: height of 25mm, speed of 2 mm/sec and weight of 5 g for the
height calibration, and a standard of 2Kg for the weight calibration.
The TPA configuration parameters were as follows: pre-test, test and post test speed of 2
mm/sec, compression by distance of 16mm (80% compression), a trigger system using force of
5g, and a waiting time between cycles of 5 seconds.
Cheese cubes of uniform 2cm by 2cm size and shape were analyzed by the texture
analyzer to obtain the TPA. All cubes were in the same position and direction on the platform.
Twelve different cubes were analyzed for each replication of each sample. After each cheese
cube was analyzed, the probe and the base of the machine were cleaned to remove residues.
The TA.XT.plus was equipped with the texture exponent software which provides several
textural parameters such as: hardness, fracturability, cohesiveness, adhesiveness, gumminess,
chewiness, springiness and resilience; all of these parameters were determined from generated
curves, similar to the one presented in the Figure 3.33, for each of the twelvecheese cube
analyzed.
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3.4.3 Microbial Growth
The basis for the microbial plate count is to dilute the bacteria to a certain level and then
trap them in or on a solid medium where the individual cells will divide and produce
macroscopic colonies, which can be counted through the transparent plate and medium (Goff et
al., 2003). A very well known nomenclature for bacteria count is a Colony Forming Unit (CFU).
Decimal dilutions (10-1 to 10-8) were made from an original solution of 11g of cheese in
99ml of PBS (phosphate-buffered saline) solution which was then put in a stomacher (Seward
model stomacher 80, Seward, England) at high speed for 120 seconds. The samples were
decimally diluted and plated on to 3M™ Petrifilm™ (3M Microbiology Products, St. Paul, MN).
The following analyses were performed: total aerobic count, E. coli and coliforms, and yeasts
and molds. The 3M™ Petrifilm™ for total aerobic plate count, and E. coli and coliform plates
were incubated for 48 hours at 37°C, and yeasts and molds plates were incubated for 72 hours at
30°C.
By convention it is determined that a plate containing 25 to 250 colonies is ideal for
counting. The cheese must be sufficiently diluted to allow one plate in the dilution sequence to
contain 25 to 250 colonies. The bacteria were counted in a Quebec Darkfield colony counter
(Reichert-Jung, Buffalo, NY). And the results of these counts were presented in logarithmic
numbers of CFU per gram that were calculated from the following equation:
log CFU/g = log (Initial dilution x Subsequent dilution x Volume plated)-1
3.4.4 Polymerase Chain Reaction
Polymerase chain reaction (PCR) is a common method of replicating specific fragments
of DNA which rapidly amplifies a single DNA molecule into many billions of molecules. The
PCR can be visualized in Figure 3.34.
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PCR is a useful tool to identify the presence of specific microorganisms due to its
specificity to certain DNA sequences. In this study, PCR was performed in order to determine
the effects of γ-Oryzanol in the starter culture of cheddar cheese which was a mixture of
Lactococcus lactis subsp. cremoris and subsp. lactis.

Figure 3.34: PCR (www.accessexcellence.org/AB/GG/polymerase.html)
Bacteria of the genus Lactococcus are used world-wide for the manufacture of fermented
dairy products.

Of particular importance are the two Lactococcus subspecies lactis and
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cremoris. It is necessary to differentiate L. lactis strains as either lactis or cremoris because of
their different characteristics in cheese manufacturing. Recently, comparison of DNA sequence
data has shown genetic differences between the two subspecies (Ward et al., 1998).
The method used in the cheddar cheese containing γ-Oryzanol to identify and
differentiate both strains relied on the PCR amplification of a 340-bp region from within the 16S
rRNA sequence using primers Y1 and Y2 (Young et al., 1991) which anneal to highly conserved
regions of the 16S rRNA sequence. This amplified region contains the sequence differences
reported between lactis and cremoris (Salama et al., 1991).
First, using the PCR amplification product, the ligase chain reaction (LCR) was used to
differentiate a single base pair difference between the lactis and cremoris sequences. Secondly,
differences in restriction endonuclease digest patterns of the PCR amplification product were
used to differentiate between the two subspecies.
The procedure to extract the bacteria from the cheese was as follows: 11g of shredded
cheddar cheese (after 4 month-storage) in 99ml PBS (phosphate-buffered saline) in dilution 1/10
was put in a stomacher Seward model stomacher 80 (Seward, England) at a high speed for 120
seconds.

A part of the resulting mixture was passed through cheesecloth to filter cheese

particles. One ml of the solution was passed through cheesecloth then centrifuged in eppendorf
tubes in a Eppendorf centrifuge model 5415C (Eppendorf-Netheler-Hinz GmbH, Hamburg,
Germany) at 3000 RPM for 3 minutes. The liquid was kept, the solid was discarded and the
liquid part was centrifuged again at 3000 RPM for another 3 minutes. The liquid part was kept
and centrifuged again at 10000 RPM for 3 minutes. The liquid part was discarded and the solid
part was resuspended by vortexing in 0.5ml of PBS until total dissolution; this part was repeated
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two more times. The final pellet was resuspended in 500µl of deionized water. Then the sample
was heated for 5 minutes at 95°C and put in ice or frozen until performing the amplification.
The GeneLab PCR primers Y1 and Y2 (BioMMED, Baton Rouge, LA) used to amplify
the 348-bp fragment from the 16S rRNA gene had the following DNA sequence: 5’-TGG CTC
AGG ACG AAC GCT GGC GGC-3’ and 5’-CCT ACT GCT GCC TCC CGT AGG AGT-3’
respectively (Ward et al., 1998). Each symbol in the sequence stands for a primary α-amino
acid, A is alanine, C is cysteine, G is glycine and T is threonine (Fennema, 1996).
Before the amplification started, the primers Y1 (546µM) and Y2 (623µM) diluted at a
ratio of 1:20 with deionized water. Next the amplification of the samples is described. In PCR
tubes, 25µl of Taq PCR master mix kit (Qiagen GmbH, Hilden, Germany), 5µl of sample, 3µl of
each primer and 14µl of water were mixed by vortexing to make a solution of 50µl.
This solution was subjected to an amplification in a Perkin Elmer gene amplifier model
PCR system 2400 (Perkin-Elmer, Wellesley, MA) to one cycle of 94°C for 5 minutes and 60°C
for 4 minutes followed by 24 cycles of 94°C for 1 minute and 60°C for 2 minutes plus 72°C for 2
minutes and kept at 4°C after the amplification was over.
The amplified Y1-Y2 product was digested with restriction endonucleases MboII as
recommended by the manufacturers (New England BioLabs, Beverly, MA). For this digestion,
25µl of the amplified product was mixed with 1µl of MboII (5000units/ml) and 24µl of NE
buffer 2 (10X concentrate) from New England BioLabs and incubated for 1 hour at 37°C.
The resulting digestion products were separated in a 1% agarose gel (by electrophoresis)
for 2.5 hours and run together with non-digested products in order to determine the presence of
both lactis subspecies.

A 5X nucleic acid sample loading buffer (Bio-Rad Laboratories,

Richmond, CA) was mixed in amount of 2µl with 8µl of the amplified product to be separated to

50

get a total of 10µl; each lane of the gel was loaded with 5µl of this mixture from different
samples. In one of the lanes, 5µl of a EZ load™ 100-bp molecular ruler of 500µg/ml (Bio-Rad
Laboratories, Richmond, CA) was loaded.
The 1% agarose gel was prepared by dissolving 0.24g of agarose I (Amresco, Solon, OH)
into 30ml of 1X TBE buffer, the mixture was brought to boil while stirring, allowed to cool for
about 5 minutes and then poured into a tray for electrophoresis. The 1X TBE buffer is a 1:10
dilution of a 10X TBE buffer solution prepared with 218g of Tris base, 110g of Boric acid and
9.3g EDTA in 2L of deionized water at pH 8.3 using NaOH. The 1X TBE buffer had to be kept
in refrigeration, and the 10X TBE buffer was kept at room temperature. The gel was run in a
Pharmacia Biotech Electrophoresis Power Supply model EPS 3500 (Pharmacia Biotech,
Sweden).
Immediately after the electrophoresis was completed, the DNA in the gel was stained
with a diluted SYBR® green I nucleic acid gel stain, 10,000X concentrate in DMSO (Molecular
probes, Eugene, OR). This diluted stain was prepared by dissolving 30µl of the concentrated
stain in a volume of 300ml. The gel was immersed in the diluted stain and agitated for 15
minutes at 40 RPM and 25°C in a Forma Scientific Orbital Shaker.
The resulting stained gel was observed under the UV light with a Hoefer machine model
MacroVue UVis-20 (Pharmacia Biotech Inc., San Francisco, CA) to identify bands which
represent the presence of the lactis subspecies. Since the cremoris PCR product is only digested
with MBoII and the Y1-Y2 amplified fragment from lactis is not digested with MboII (Ward et
al., 1998), it is expected to see in the gel two bands for the digested products, only one band for
the non-digested ones; these bands in the gel will acquaint with the presence of each subspecies
of Lactococcus lactis.
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3.4.5 Aroma Development
A common challenge when analyzing flavors and aromas from complex mixtures
involves finding the best method.

Fortunately, most aroma chemicals are volatile, and

procedures for their isolation from foods and flavors have been established. An ideal approach
to flavor isolation and analysis would provide an analytical sample whose composition is
identical to the chemical mixture within the matrix, which is free of solvents and other impurities
and could be completed within a few minutes with no intermediate processing of the samples.
Solid-phase microextraction (SPME) approaches this ideal.
Figure 3.35 describes the apparatus used to extract the volatiles from cheese. The bottom
centimeter of the fused silica fiber is coated with a relatively thin film of any of several
stationary phases. This film serves as the organic “solvent” during the absorption of the volatile
compounds from the analytical matrix. The needle functions to puncture the septa sealing of
both the sample container and the GC injection port and to protect the fragile fused silica fiber
during storage and use. A Supelco fiber of 100µm PDMS (polydimethylsiloxane) for Merlin
Microseal™ (Supelco, Bellefonte, PA) was used for the study of aroma development in cheese.
In a 50ml volumetric flask, one gram of shredded cheese was placed; then 1ml of distilled
water was added, afterwards, 0.5ml of internal standard (4-methy-2-pentanone solution of
0.005µl/ml of hexane) was added.

The mixture was thoroughly mixed for a few seconds

(equilibration rate increases), sealed with the septum type cap and the fiber inserted through the
septa. Immediately afterward, the flask was put in the water bath at 65°C for 20 minutes.
The SPME process is illustrated in Figure 3.36 which is similar to the one we used in the
analysis of cheese. During headspace sampling the PDMS fiber is extended into the vapor phase
above the sample. After 20 minutes, the fiber was taken out of the flask and injected into the
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GC-MS Varian model Saturn 2200 with a gas chromatograph Varian model CP-3800 (Varian
Chromatography Systems, Walnut Creek, CA) with FID (flame ionization detector) for
separation and analysis of the volatiles.

Figure 3.35: Graphic representation of a solid-phase microextraction (SPME) device (Zhang et
al., 1994).
The mobile phase of the system was helium at a flow rate of 0.8ml/min. The oven
temperature started at 30°C and held for 2.5 minutes, then it was increased to 45°C at a rate of
2°C/min; as soon as the temperature reached 45°C, the increase rate was of 5°C per minute until
the oven temperature reached 180°C. Then the temperature was increased to 200°C at a rate of
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20°C per minute, and this temperature was held for 2 minutes to make a total analysis time of 40
minutes.

Figure 3.36: Sequence of events showing extraction steps and desorption (injection) steps
followed to perform an analysis using SPME. The fiber is inserted directly into a liquid sample
with the subsequent absorption of most of the analyte molecules (small circles) from the solution
(Marsili, 1997).
The chromatograms obtained from the GC-MS helped to determine the most important
aroma and flavor peaks in the samples and their changes during ripening, which were measured
by their height (kilocounts) since the software available could not quantify the peaks.
3.4.6 Oryzanol Retention
Since γ-Oryzanol is fat soluble, the first part of the analysis was to extract the lipid
fraction of the cheese. 5ml of a Chloroform-Methanol 2:1 solution (solvent) was added to a flask
containing 1g of shredded cheese and then mixed in a vortex for several seconds (until total
destruction of cheese texture). This mixture was heated and agitated constantly in a water bath at
40°C for 10 minutes, then mixed in a vortex again for a few seconds. The blend was then
centrifuged at 2500 RPM and 20°C for 5 minutes.
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The liquid part was put in another flask in a rotary evaporator under vacuum at 60°C to
obtain crude oil (Xu et al., 1999). The solid part was treated as follows: 5ml of hexane (solvent)
was added and then mixed in a vortex for several seconds the new blend was centrifuged again at
2500 RPM and 20°C for 5 minutes, and the liquid part was separated from the solid. This whole
process was repeated two more times.
Once the three extractions with hexane were done, the solid part was discarded, and after
all the solvent was evaporated, the samples were prepared to be analyzed by HPLC. The
extracted liquid which contained all the lipids (crude oil) from the cheese was dissolved in 5ml
of hexane and put in vials for analysis.
The dissolved samples were injected into the HPLC system consisting of a Waters™ 486
tunable absorbance detector, a Waters™ 717plus autosampler and a Waters™ 470 scanning
fluorescence detector for separation and analysis of γ-Oryzanol in the lipid extraction. The
chromatograms obtained from the HPLC were used to determine the concentration of γ-Oryzanol
retained in the cheese. The software calculated the area under the oryzanol peaks and its
concentration was calculated using the following parameters:
The calibration curve between area under the peak and oryzanol content is:
Peak area = 123368 x oryzanol content (µg)
Injection volume: 25µl of extracted lipid sample
Dilution factor: 5ml of hexane
Serving size of cheddar cheese: 28g
With these parameters mentioned above and making conversions between µg and mg, and µl and
ml, the following equations were used to determine the concentration of oryzanol in a serving
size of cheddar cheese (mg/serving size):
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Oryzanol content (µg) =

Oryzanol = Oryzanol content (µg) ×

Peak area
123368

5ml × 1000µl / ml
28g
×
25µl × 1000µg / mg Sample weight (g)

3.4.7 Moisture Content

The moisture content was determined by means of a microwave oven which uses
microwave energy to heat samples to remove moisture. Factors affecting the drying are time,
sample size, placement of sample in oven, and energy of microwaves (Richardson, 1985).
The microwave oven used for this analysis was a CEM model Smart System 5 (CEM
Corp., Matthews, NC) with the following parameters set: weight range of 2-4 grams, a power of
100%, delta weight of 0.5mg, delta time of 10 seconds, maximum time of 4 minutes, maximum
temperature of 130°C and no weight compensation.
Shredded cheese (2 to 3 grams) was put between CEM square sample pads specific for
this machine (part # 200150, CEM Corp., Matthews, NC) and then analyzed.
3.4.8 Free Fatty Acid Profile

The method used to analyze the free fatty acid profile of the cheese was similar to the one
used for the determination of the oryzanol retention (section 3.4.6), however, with slight
changes.
The first part of the analysis was to extract the lipid fraction of the cheese. 5ml of a
Chloroform-Methanol 2:1 solution (solvent) was added to a flask containing 1g of shredded
cheese and 1ml of a solution of internal standard consisting of 0.4652g of heptadecanoic acid
(C17:0) in 50ml of hexane (C6H14). The mixture was mixed in a vortex for several seconds until
total destruction of cheese texture. This mixture was heated and agitated constantly in a water
bath at 40°C for 10 minutes, and then mixed in a vortex again for a few seconds. The blend was
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then centrifuged at 2500 RPM and 20°C for 5 minutes in a Hermle Labnet centrifuge model
Z383K (Hermle Labortechnik, Wehingen, Germany).
The liquid part was poured in another flask in a Labconco rotary evaporator model
CentriVap Console under vacuum at 60°C to obtain crude oil (Xu et al., 1999). The solid part
was treated as follows: 5ml of hexane (solvent) was added and then mixed in a vortex for several
seconds; the new blend was centrifuged again at 2500 RPM and 20°C for 5 minutes, and the
liquid phase was separated from the solid. The evaporation process was performed two more
times.
Once the three extractions with hexane were done, the solid part was discarded, and after
all the solvent was evaporated, the samples were prepared to be analyzed by GC. The extracted
liquid which contained all the lipids (crude oil) from the cheese was dissolved in 6ml of hexane
together with 2ml of a solution of Boron trichloride (BCl3) and methanol (Supelco, Bellefonte,
PA) and 1ml of 2,2-dimethoxypropane (Sigma-Aldrich Co., St. Louis, MO). After agitating in
vortex for a few seconds, the upper layer (hexane) was transferred to a test tube where a few
crystals of sodium sulfate anhydrous (NaSO4) were added to absorb moisture, and then the
hexane extract was transferred to GC sample vials ready for analysis.
The hexane extract samples were injected into the gas chromatograph Hewlett Packard
model 5890A (HP, San Fernando, CA) for separation and analysis of free fatty acids between C4
and C18 in the lipid extraction.

The mobile phase of the system was Helium.

The

chromatograms obtained from the GC were used to help determining the concentration of the
different fatty acids present in the cheese. The software calculated the areas under the peaks and
their concentrations were calculated using the following parameters:
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The relationship between peak areas and concentrations (conc.) of a free fatty acid (FFA) and
internal standard (I.S.) is:
Area FFA FFA conc.
=
Area I.S.
I.S. conc.
Injection volume: 3µl of extracted lipid sample
Dilution factor: 6ml of hexane
I.S. concentration: 0.4652g/50ml hexane
I.S. solution volume: 1ml
With these parameters mentioned above and making conversions between µg and mg, grams and
Kg, and µl and ml, the following equations were used to determine the concentration of each free
fatty acid in the cheese (mg/Kg of cheese):
I.S. conc.(mg / Kg) =

0.4652g × 1ml × 3µl × 1000mg / g × 1000g / Kg
50ml × 6ml × 1000µl / ml × Sample weight (g)

FFA conc.(mg / Kg) = I.S. conc.(mg / Kg) ×

Area FFA
Area I.S.

The results for the free fatty acid profile were expressed in percentage based on the total
amount of each FFA from C4 to C18, and the total amount of all FFA together.
3.5 Consumer Study

With the aim of understanding prospective buyers of a specific product and how this
product can be introduced into the market, the use of sensory affective tests can assist food
scientists and developers to understand the behavior of different consumers groups (Piggot,
1988). This type of affective test is a very accurate tool in recognizing consumer preferences.
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Quantitative affective tests determine responses of a large group of consumers to a set of
questions regarding preference, liking, sensory attributes, etc. (Meilgaard et al., 1999). They
obtain more data and information in less time than do qualitative tests.
The hedonic scale is a common tool to quantify consumer acceptance. The 9-point
hedonic scale is a rating scale that has been used for many years in sensory evaluation in the food
industry to determine the acceptance of a food and to provide a bench mark for comparison. Its
use has been validated in the scientific literature (Stone et al., 1993). The number of scale
categories that have been used include the 5-, 7- and 9-point scale. The 3-point scale is not
recommended for use with adult consumers, because adults tend to avoid using the extreme
points of the scale in rating food product samples (Resurreccion, 1998).
Overall appearance includes all visible sensory attributes such as color, size, shape and
surface texture. Appearance is commonly used by consumers to infer food product quality;
frequently this is the only cue available, especially at the moment of purchase (Schröder, 2003).
Flavor involves attributes like taste, specific flavors, aroma, etc. Aroma is the odor of a food
resulting from the process that involves the passing of volatiles through the nasal passages
located in the nose when a person inhales them (Meilgaard et al., 1999). Overall liking can be
defined as a complex expression of liking of the product as a whole (Pavon, 2003).
In order to find if consumers can detect overall difference and/or difference in a specific
attribute(s) between two or more samples, discriminative sensory testing can be utilized. The
applications of these tests are to determine if products differ due to changes in ingredients,
processing, storage, etc., if an overall difference exists where no specific attribute(s) can be
identified as having been affected, if a specific attribute(s) of the products differ or if the
consumer is able to discriminate between test samples.
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The traditional R-Index method and the bipolar and/or weighted R-Index method are
discriminatory sensory tests from which the researcher can determine if panelists can detect
differences in specific attributes between samples. Both methods present a signal (S) sample that
is the new, reformulated, or improved product and the noise (N) sample which is the current,
existing, or control product. The panelists’ task is to indicate if he/she is sure or not sure that
samples are different or the same. They can also indicate if the samples are more or less intense
in specific attributes.

The R-Index is a probability value of a given judge distinguishing

correctly between 2 samples.
Research was conducted including four parts, a consent form (see Appendix B), a
demographic and socioeconomic survey, an affective test, and the R-index with the traditional
method and the bipolar method (see Appendix C). The consent form included some general
explanation of the questionnaire to be filled by the panelist, stating the presence of potential
allergens, contact information in case of interest in further knowledge about the topic and the
purpose of the study; the demographic and socioeconomic survey asking age, gender, race, level
of education and household income; the affective test included the rating of the overall
appearance, smoothness of color (yellowness), odor/aroma, taste, overall texture/mouthfeel and
overall liking with a 9-point hedonic scale (1=dislike extremely, 5=neither like nor dislike, and
9=like extremely) (Peryam et al., 1957). The affective test asked consumers to evaluate the
detection of a bitter aftertaste, the acceptance and the interest in buying a cheddar cheese
containing γ-Oryzanol, an antioxidant and potential cholesterol reducing compound from rice
bran using a yes/no scale (Moskowitz, 1994). The R-Index included the overall appearance,
overall color and yellowness for the visual evaluation, odor for the aroma evaluation, taste,
overall texture, hardness and chewiness for the gustatory evaluation. The yellowness, hardness
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and chewiness were evaluated as a bipolar R-index, the rest were treated as the traditional RIndex.
Untrained consumers (n=100) were randomly recruited from Louisiana State University
(LSU) campus and vicinities in Baton Rouge. The recruitment consisted of flyers, phone calls,
emails and posting advertisements on LSU campus. Requirements to be a panelist were: (1) to
be at least 18 years old, (2) not having allergic reactions to cheese and rice products and (3)
positive attitude with disposition of time to complete a questionnaire. The consumer session was
carried out on May 29th, 2004, between 10 a.m. and 4 p.m. in the dairy store of the Dairy Science
department in LSU.
Consumers were instructed on the procedure to be followed. They were informed that
each sample was randomly coded with a 3-digit number, 705 for control and 485 for treatment.
They were familiarized with the (S) signal and (N) noise samples, and asked whether they were
sure or not sure that samples were different or the same.

They were also asked whether they

were sure or not sure that samples were more or less intense in specific attributes.
The sample preparation consisted of trimming the outer portion of the block cheese
(Figure 3.37). Samples were not allowed to dry out by wrapping them with plastic to prevent
loss of moisture, and they were kept refrigerated. Samples were cut to 2cm cubes with a cheese
wire (Figure 3.38). Although cheese should be stored in the refrigerator, cheese was removed to
allow enough time to equilibrate twenty to thirty minutes before being served to the consumers at
ambient temperature (Resurreccion, 1998).
The samples were served to the seated panelists on a tray with a cup of drinking water at
room temperature, unsalted crackers, toothstick and a napkin as shown in Figure 3.39, in a room
with controlled light, positive airflow and free of distracting odors, together with an explanation
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of the procedure to follow and the questionnaire including the four parts mentioned above in this
section.

Figure 3.37: Trimming outer part of block cheese.

Figure 3.38: Cutting cheese samples to 2cm-cubes with a cheese wire.
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Figure 3.39: Sample presentation for consumer study.
3.6 Statistical Analysis
3.6.1 Physicochemical and Biological Analysis

The statistical analysis of color, texture, microbial growth, aroma development, oryzanol
retention, moisture content and free fatty acid profile was performed using the software SAS
version 9.00, 2002 (SAS Institute Inc., Cary, NC) (SAS codes are in Appendix D).
The GLM or ANOVA test was used to test the null hypothesis H0: µcontrol = µtreatment with
an alternative hypothesis H1: µcontrol ≠ µtreatment, and Tukey’s honestly significant difference
(HSD) test with the studentized range was applied to determine significant differences in each
sample (control and treatment analyzed separately) within different ripening times.

The

significance level (α) for this test was set at 0.05.
A two-sample t-test was used for the null hypothesis H0: µcontrol - µtreatment = 0 and an
alternative hypothesis H1: µcontrol - µtreatment ≠ 0 to determine if there were significant differences
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between samples (control and treatment). This test, by the F test of variances with a significance
level (α) of 0.2, judged if two estimates of variance from different populations could be
combined; pooling variances together turns into a single more powerful variance and the
following assumptions are taken: the differences are normally distributed, the observations and
samples are independent and the variance is homogenous (Freund et al., 1997). Whether the
variances can be pooled together or not, SAS gives probabilities for equal and unequal variances.
The second part of the two-sample t-test uses a significance level (α) of 0.05 for the t-test which
determine significant differences found between samples using the hypotheses mentioned at the
beginning of this paragraph.
3.6.2 Sensory Evaluation
3.6.2.1 R-Index

To determine if an overall difference exists in the cheese containing γ-Oryzanol and
whether the cheese differs due to the presence of γ-Oryzanol, the discriminative sensory test, i.e.,
R-Index was used (traditional and bipolar tests). The traditional R-Index indicates the degree of
difference between the S (signal) and N (noise) samples; a higher R-Index value indicates better
discrimination.
For the traditional R-Index, the data obtained from the questionnaire were: consumer was
certain that the sample was the treatment (S), that perhaps the sample was the treatment but not
sure (S?), that perhaps the sample was the control but not sure (N?) or that definitely the sample
was the control (N). With this data tabulated, the Table 3.1 was built.
From data tabulated as shown in Table 3.1, the traditional R-Index in percentage could be
calculated with the following equation:
R − Index =

[a × (f + g + h ) + b × (g + h ) + ch ] + [0.5 × (ae + bf + cg + dh )] × 100
(a + b + c + d ) × (e + f + g + h )
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Table 3.1: Tabulated information needed to calculate the traditional R-Index.
Consumer’s responses

Sample

Total
(code)

S

S?

N?

N

S (485)

a

b

c

d

ns=a+b+c+d

N (705)

e

f

g

h

nN=e+f+g+h

S (485) = cheese containing γ-Oryzanol; N (705) = cheese without γ-Oryzanol; S= different sure;
S?= different unsure; N?= same unsure; N= same sure.
The Table with critical values of R-Index expressed in % of R-Index-50% (Bi et al.,
1995) was used to determine the critical R-Index value by using the number of signal or noise
samples (N) to obtain the R-Index in the equation above and the significance level (α) for a 1tailed or 2-tailed test. If the researcher knows that the signal can only be stronger or weaker than
the noise then the test is 1-tailed, otherwise it is a 2-tailed test. For the traditional R-Index, the
calculations were made based on a 2-tailed test since assumptions were not made about
differences between samples. The null hypothesis (H0: the %R-Index is equal to a chance
(50%)) tells whether the consumer detected a difference in the samples by guessing or by chance.
If the R-Index value obtained from the equation above was equal to or greater than the
critical value, then the consumer noticed a difference between samples not by chance. If this
value was smaller than the critical value, then the consumer either noticed a difference between
samples most probably by chance or could not differentiate the samples.
For the bipolar R-Index, the data obtained from the questionnaire was: in one part, that
the consumer was certain the sample had more intensity of the attribute than the control (S+),
that perhaps the sample had more intensity of the attribute than the control (S+?), that perhaps
the sample had the same intensity of the attribute than the control but not sure (N?) or that
definitely the sample had the same intensity than the control (N); in the other part, that the
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consumer was certain the sample had less intensity of the attribute than the control (S-), that
perhaps the sample had less intensity of the attribute than the control (S-?), that perhaps the
sample had the same intensity of the attribute than the control but not sure (N?) or that definitely
the sample had the same intensity than the control (N). With this data tabulated, tables like
Table 3.2 and 3.3 could be built.
From data tabulated as shown in the Tables 3.2 and 3.3, the bipolar R-Indices (Rmore and
Rless) could be calculated with the same equation used for the traditional R-Index. The critical RIndex value for the bipolar method was calculated the same way as the traditional R-Index was
done with the only change that it was a 1-tailed test.
Table 3.2: Tabulated information needed to calculate the bipolar R-Index (Rmore).
Consumer’s responses

Sample

Total
(code)

S+

S+?

N?

N

S (485)

a

b

c

d

ns=a+b+c+d

N (705)

e

f

g

h

nN=e+f+g+h

S (485) = cheese containing γ-Oryzanol; N (705) = cheese without γ-Oryzanol; S+= more sure;
S+?= more unsure; N?= same unsure; N= same sure.
Table 3.3: Tabulated information needed to calculate the bipolar R-Index (Rless).
Consumer’s responses

Sample

Total
(code)

S-

S-?

N?

N

S (485)

a

b

c

d

ns=a+b+c+d

N (705)

e

f

g

h

nN=e+f+g+h

S (485) = cheese containing γ-Oryzanol; N (705) = cheese without γ-Oryzanol; S-= less sure;
S-?= less unsure; N?= same unsure; N= same sure.
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The decision of taking Rmore or Rless as the real R-Index value was based on the frequency
of repetition of S+ and S+?, and S- and S-?. The ones with the highest proportion would be the
R-Index value taken. If there was not a big difference in the frequency of repetition of S+ and
S+?, and S- and S-?, either R-Indices values could be taken, or the calculations could be done as
a traditional R-Index method, like mentioned above.
3.6.2.2 The McNemar Test

With the intention of analyzing the change in probability of purchase intent before and
after consumers had been informed about the potential health benefits of the cheese, the
McNemar test was performed using proc freq/agree of software SAS version 9.00, 2002 (SAS
Institute Inc., Cary, NC) (code is in Appendix D).
The McNemar test represents a comparison of dependent proportions for binary response
variables, and it is a two-related sample difference test that follows a Chi-square (χ2) distribution
with a degree of freedom (df) of one (Agresti, 1996). Consumers are categorized in two
categories: before they have been informed about health benefits of cheese containing γOryzanol and after they have been informed about the health benefits (O’Mahony, 1986).
The null hypothesis (H0: π+1 = π1+) states that there is no significant difference in the
probability of buying the cheese before and after consumers had been informed about its health
benefits (π+1 is the probability of those who answered yes after, and π1+ is the probability of
those who answered yes before). The aim of this test is to know if participants were influenced
or not by the health benefits of this product and, therefore, to determine if their opinions changed
from a “before” status to an “after” status.
To complement McNemar test and obtain more detailed understanding about changes in
consumer purchase decision, a 95% confidence interval for the difference of proportions was
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calculated. The difference of two sample marginal proportions (p+1 - p1+) estimates the true
difference (π+1 - π1+ or π21 – π12). The sample proportions were calculated using the next
equation:
pij = nij/N
where nij is the number of subjects making response i at the first question (before), and response j
at the second question (after knowing that the product contained health promoting ingredients),
and N is the total number of responses. The confidence interval of difference of proportions is
calculated as follows:
(p+1 - p1+)±zα/2(ASE)
where (p+1 - p1+) indicates the difference between the proportion of participants that answered
“yes” after knowing that the cheese contained health promoting compounds p+1, and the
proportion of participants that answered “yes” before knowing that the product contained health
promoting ingredients (p1+); the zα/2 denotes the standard normal percentile having a right-tail
probability equal to α/2; ASE is the estimated standard error for the proportion difference.
ASE is calculated with the following equation:
ASE =

p1+ × (1 − p1+ ) + p +1 × (1 − p +1 ) − 2 × (p11 × p 22 − p12 × p 21 )
N

where p11 is the proportion of subjects that answered “yes” before knowing and “yes” after
knowing, p22 is the proportion of subjects that answered “no” before knowing and “no” after
knowing, p12 is the proportion of subjects that answered “yes” before knowing and “no” after
knowing, and p21 is the proportion of subjects that answered “no” before knowing and “yes” after
knowing. When 0 is included in the confidence interval, then there is no significant difference.
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3.6.2.3 Consumer Acceptance Test

Univariate and multivariate statistical analyses were performed to determine consumers’
perceptions and preferences in the acceptability of each different sensory attribute as well as in
overall liking of the cheese samples by using the software SAS version 9.00, 2002 (SAS Institute
Inc., Cary, NC) (codes are in Appendix D).
An analysis of variance (ANOVA) was used to determine differences in acceptability for
each of the sensory attributes among the samples, and Tukey’s honestly significant difference
(HSD) test with studentized range, which can be applied regardless of whether the overall test for
differences is significant among the samples (Meilgaard et al., 1999), was applied to determine if
the samples were significantly different. The significance level (α) for this test was set at 0.05.
A multivariate analysis of variance (MANOVA) was performed as an extension of the
ANOVA test. However, more than one variable is tested to detect differences in groups across
multiple dependent variables at the same time (Pavon, 2003). MANOVA can determine overall
differences in the acceptability among the samples, including all sensory attributes
simultaneously.
Descriptive discriminant analysis (DDA) was done to identify any discriminating sensory
acceptability attributes that may have contributed to differences among samples and to the
cheese in general.
Logistic regression models are useful to describe the effect of predictors (independent
variables) on a binary dichotomous response variable (dependent variable), which follows an Sshaped curve (Agresti, 1996). Logistic regression was used to predict acceptance by using what
is known as the odds ratio estimate.
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When an estimated odds ratio equals 1.0, it means that there is no significant association
between the two variables (Agresti, 1996). To be precise, the probability of success remains
constant through the change of the independent variables. The higher the odds ratio estimate is,
the more contribution from that specific attribute exists to the acceptability of the sample.
For the detection of a bitterness aftertaste, the acceptability of the cheese, and the interest
in buying the cheddar cheese containing γ-Oryzanol before and after knowing the potential
health benefits of it, a simple frequency analysis was performed.
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CHAPTER 4. RESULTS AND DISCUSSION
4.1 Color
The analysis of variance and a post-hoc test indicated an existence of significant
differences (p<0.0001) in all color parameters in cheese during ripening process. Pairwise tests
between some months based on whiteness (L*), redness (a*), yellowness (b*) and huge angle
(H°) measurements showed significant differences (p<0.05) for both control and treatment
samples (Tables 4.1 and 4.2). L* and a* decreased for both control and treatment samples
during time, and b* and H° increased in both samples, which means that there was less red and
white and more yellow in the sample during ripening. The significant differences were noticed
after one and two months of maturation for both samples but the treatment also showed
differences in the month 4.
Table 4.1: Means and standard deviations of L* (lightness), a* (redness), b* (yellowness) and
H° (hue angle) of control samples without γ-Oryzanol at different stages of maturation.
Parameter
Month
L*

a*

b*

H°

0

78.11 (1.37)a

10.46 (1.27)a

34.56 (1.64)c

73.22 (1.26)b

1

75.74 (1.27)b

11.22 (1.02)a

37.15 (2.21)b

73.22 (0.92)b

2

75.65 (1.79)b

7.79 (0.98)b

39.45 (2.30)a

78.80 (1.12)a

3

75.78 (1.63)b

7.81 (1.16)b

39.29 (2.07)a

78.79 (1.28)a

4

74.83 (1.38)b

8.09 (1.05)b

40.93 (3.16)a

78.83 (1.06)a

a,b,c

Means within same column followed by different superscripts are significantly different
(P<0.05).
When comparing color parameters between samples (control and treatment) at different
stages of maturation, the significant differences were observed (Table 4.3). L* and b* showed
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less significant differences between samples than a* and H°, and the former two parameters had
significant differences up to the third month of maturation, L* had them between the first and
third month and b* just in the first and third month.
Table 4.2: Means and standard deviations of L* (lightness), a* (redness), b* (yellowness) and
H° (hue angle) of treatment samples with γ-Oryzanol at different stages of maturation.
Parameter
Month
L*

a*

b*

H°

0

77.46 (1.54)ab

9.60 (1.06)b

34.30 (1.82)c

74.40 (1.21)c

1

76.96 (0.80)ab

10.35 (0.61)a

35.65 (1.61)bc

73.81 (0.60)c

2

76.63 (0.89)b

6.93 (0.72)d

39.23 (2.75)a

79.99 (0.51)a

3

77.85 (0.59)a

6.53 (0.50)d

36.93 (2.02)b

79.97 (0.64)a

4

75.58 (2.07)c

7.65 (1.15)c

39.46 (3.29)a

79.04 (1.32)b

a,b,c,d

Means within same column followed by different superscripts are significantly different
(P<0.05).
Table 4.3: Probabilities of significant differences (Pr>|t|) in L* (lightness), a* (redness), b*
(yellowness) and H° (hue angle) between control (without γ-Oryzanol) and treatment (with γOryzanol) samples during ripening.
Parameter
Month
L*

a*

b*

H°

0

0.1279

0.0142*

0.6153

0.0019*

1

0.0003*

0.001*

0.0103*

0.0112*

2

0.0235*

0.0014*

0.7608

<0.0001*

3

<0.0001*

<0.0001*

0.0002*

0.0003*

4

0.1456

0.1719

0.1210

0.5444

*Probabilities smaller than 0.05 (α) indicate significant differences between samples.
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Total color difference was calculated in two different ways: comparing control and
treatment samples at different stages of ripening (Figure 4.1), and comparing each sample at
different months with the control sample at month 0 (Figure 4.2). From these figures, it can be
seen that there is a slight increase in color difference (∆E*) during the ripening of the cheese.
It cannot be said that there is a clear tendency of the color difference to increase during
maturation of cheese when comparing the ∆E* in Figure 4.1, just that there is a difference in
color between control and treatment samples at different stages of maturation.

4.0

3.40

3.5
3.0

2.12

∆E*

2.5

1.71

2.0
1.5

1.30

1.11

1.0
0.5
0.0
0

1

2

3

4

Ripening time (months)
Figure 4.1: Total color difference (∆E*) between control (without γ-Oryzanol) and treatment
(with γ-Oryzanol) samples at different stages of cheese ripening.
It can be concluded that the difference in color for months 1, 2, 3 and 4 is higher than
month 0. This means that the difference between control and treatment is larger.
In Figure 4.2, it can be noted that during the ripening process, the color difference of each
sample at each stage of ripening compared with the control sample at month 0 tends to be
smaller for the treatment samples than for the control.
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From the obtained results of color parameters (L*, a*, b* and H°) and total color
difference (∆E*), and the subsequent statistical analysis, it can be concluded that γ-Oryzanol was
not an important factor affecting the color difference of cheddar cheese. Also time was a
significant factor affecting the color changes in cheese since both comparisons (Figure 4.1 and
4.2) showed an increase of color differences during time.

8.0

7.55

7.0

4.59

5.0
∆E*

6.19

6.09 6.03 5.91

6.0

Control
Treatlment

3.60

4.0
3.0
2.0
1.0
0.0

1.11

1.59

0.00
0

1

2

3

4

Ripening time (months)

Figure 4.2: Total color difference (∆E*) comparing samples with γ-Oryzanol and without γOryzanol at all times with the control sample (without γ-Oryzanol) at month 0.
4.2 Texture
The results of textural parameters obtained from the texture exponent software for both
control and treatment samples are presented in Tables 4.4 and 4.5, respectively.

These tables

also show the significant differences when comparing each sample within different months of
ripening. The analysis of variance and a post-hoc test indicated an existence of significant
differences (p<0.0001) in all textural parameters evaluated in cheese during the ripening process.
Pairwise tests between some months within the same sample based on hardness, cohesiveness,
adhesiveness, gumminess, chewiness, springiness and resilience results were significantly
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different (p<0.05) for both control and treatment samples. The most important changes were in
the hardness and gumminess which decreased during time over the four months of the study for
both control and treatment samples. The other parameters also decreased during time but in a
smaller ratio.
Springiness and resilience showed to have more differences between months for both
control and treatment than the other textural parameters evaluated. Cohesiveness showed more
significant differences in treatment samples; hardness had less significant differences than the
other parameters in question for both samples, and chewiness and gumminess showed the same
degree of difference between months for both samples, being between springiness and resilience,
and hardness.
Table 4.4: Means and standard deviations of textural parameters of control samples without γOryzanol at different stages of maturation.
Parameter
Month

Hardness Cohesiveness Gumminess Chewiness Springiness Resilience
(N)
(-)
(N)
(J)
(m)
(-)
0
215.33
0.27
58.25
0.78
0.01
0.13
(34.68)a
(0.03)a
(12.31)a
(0.18)a
(0.00)a
(0.01)a
0.22
36.52
0.44
0.01
0.11
1
157.18
b
b
b
b
b
(0.03)
(23.02)
(0.26)
(0.00)
(0.02)b
(72.42)
2
165.73
0.20
34.23
0.32
0.01
0.09
(0.02)bc
(13.72)bc
(0.12)bc
(0.00)c
(0.01)c
(57.13)b
3
129.72
0.19
24.97
0.22
0.01
0.08
(32.25)b
(0.03)c
(7.23)c
(0.05)c
(0.00)c
(0.01)d
4
145.94
0.21
30.63
0.25
0.01
0.08
(30.49)b
(0.02)bc
(8.42)bc
(0.06)c
(0.00)d
(0.01)cd
a,b,c,d
Means within same column followed by different superscripts are significantly different
(P<0.05).
The adhesiveness is not included in the Tables 4.4 and 4.5 because both samples, control
and treatment, gave an adhesiveness of 0 Joules at all times. The fracturability is also not
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included in the results because it was present in just few samples and replications, and it was not
representative of the behavior of textural changes.
Table 4.5: Means and standard deviations of textural parameters of treatment samples with γOryzanol at different stages of maturation.
Parameter
Month

Hardness Cohesiveness Gumminess Chewiness Springiness Resilience
(N)
(-)
(N)
(J)
(m)
(-)
0
170.73
0.26
45.39
0.58
0.01
0.13
(53.37)a
(0.04)a
(21.01)a
(0.26)a
(0.00)a
(0.02)a
1
146.87
0.22
32.28
0.37
0.01
0.11
ab
bc
bc
b
b
(43.66)
(0.03)
(13.48)
(0.16)
(0.00)
(0.01)b
2
179.85
0.20
36.52
0.33
0.01
0.10
a
c
ab
b
c
(50.32)
(0.03)
(14.83)
(0.14)
(0.00)
(0.02)c
3
121.93
0.17
21.30
0.19
0.01
0.08
b
d
c
c
cd
(27.20)
(0.02)
(6.22)
(0.06)
(0.00)
(0.01)d
0.22
36.36
0.28
0.01
0.09
4
161.44
(0.03)b
(11.94)ab
(0.07)bc
(0.00)d
(0.01)c
(46.23)a
a,b,c,d
Means within same column followed by different superscripts are significantly different
(P<0.05).
When comparing the results of hardness, cohesiveness, gumminess, chewiness,
springiness and resilience between samples (control and treatment) at different stages of
maturation, the differences seemed to be not very significant, as shown in Table 4.6. Just few
pair-wise comparisons between control and treatment at a specific stage of the maturation give
the impression to be significantly different, and the rest does not show any significant difference
at all.

Cohesiveness showed more differences at the third and fourth month, hardness,

gumminess and chewiness at month 0, and resilience at the last month of analysis; springiness
showed significant changes in the first month, and chewiness also showed changes in month 3.
Hardness, cohesiveness, gumminess, chewiness, springiness and resilience showed
significant differences when compared between months within the same sample; they barely
showed significant differences when compared between samples of the same maturation time.
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Adhesiveness showed to be the only textural parameter which did not show a significant
difference at all, 0 Joules for all times, samples and replications.
Table 4.6: Probabilities of significant differences (Pr>|t|) in texture parameters between control
(without γ-Oryzanol) and treatment (with γ-Oryzanol) samples during ripening.
Parameter
Month
Hardness Cohesiveness Gumminess Chewiness Springiness Resilience
0
0.0014*
0.1953
0.0137*
0.0043*
0.2044
0.4699
1
0.5540
0.5180
0.4418
0.2397
0.0123*
0.2700
2
0.3726
0.3945
0.5866
0.8895
0.3572
0.2465
3
0.3714
0.0078*
0.0685
0.0272*
0.4994
0.1628
4
0.1779
0.0216*
0.0614
0.1020
0.2979
0.0125*
*Probabilities smaller than 0.05 (α) indicate significant differences between samples.
Texture profile analysis showed some differences during ripening within the same
samples but it did not show any major differences between control and treatment cheese samples
during this time; all of which leads to the conclusion that γ-Oryzanol did not change textural
conformation of cheddar cheese significantly.
All textural parameters evaluated, with exception of springiness, tended to decrease
during time until the third month, and the fourth month showed a slight increase. For springiness
there was not any increase in the fourth month, including both control and treatment samples (see
Figures 4.5 to 4.10 in Appendix A for graphical trend of data in Tables 4.4 and 4.5).
4.3 Microbial Growth
The pattern of aerobic bacteria and coliform growth in both control and treatment
samples during maturation is presented in Table 4.7. In this table, it can be seen the significant
differences existing when comparing each sample within different months of ripening.
The analysis of variance and a post-hoc test indicated an existence of significant
differences (p<0.0208 for aerobic bacteria and p<0.0001 for coliforms) in microbial growth in
cheese during the ripening process. Pairwise comparisons between some months based on
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aerobic plate count and coliform count were significantly different (p<0.05) for both control and
treatment samples.
Table 4.7: Means and standard deviations of microbial growth of control (without γ-Oryzanol)
and treatment (with γ-Oryzanol) samples at different stages of maturation.
Microbial count
Month

Aerobic Plate (log CFU/g)

Coliform Plate (log CFU/g)

Control

Treatment

Control

Treatment

0

6.74 (0.36)a

6.71 (0.23)a

4.36 (0.31)a

4.53 (0.07)a

1

6.44 (0.26)ab

6.68 (0.06)a

2.83 (0.18)b

1.48 (2.09))ab

2

5.29 (0.12)ab

5.66 (0.08)b

2.50 (0.28)b

2.39 (0.55)ab

3

5.32 (0.72)ab

5.34 (0.37)b

ND

ND

4

5.02 (0.04)b

5.19 (0.07)b

ND

ND

a,b,c

Means within same column followed by different superscripts are significantly different
(P<0.05).
ND = not detectable; detection limit: 10 CFU/g.
The decline in both coliforms and aerobic bacteria for both samples over time could have
been due to the acid production of the lactic acid bacteria used in the starter culture which slowly
decreased the aerobic bacteria and coliform counts over time.
Yeasts and molds were not present in any of the samples at different stages of maturation
with the method and conditions used in the experiment. E. coli was not present in any of the
samples either; Reddy et al., (1995) did not detect E. coli either, but Reitsma et al., (1996) found
that E. coli O157:H7 survived during manufacture and for more than 60 days of curing of
cheddar cheese.
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When comparing the results of aerobic bacteria and coliforms between samples (control
and treatment) at different stages of maturation, these did not show any significant differences, as
shown in Table 4.8, which means that treated samples did not diverge on its quality from control
samples during maturation.
The aerobic plate count in both samples, control without γ-Oryzanol and treatment with
γ-Oryzanol, was significantly lower than the counts presented by Reddy et al., (1995), at least 3
orders of magnitude at all stages of maturation.
Table 4.8: Probabilities of significant differences (Pr>|t|) in aerobic bacteria and coliform
population between control (without γ-Oryzanol) and treatment (with γ-Oryzanol) samples
during ripening.
Microbial count
Month
Aerobic Plate

Coliform Plate

0

0.9303

0.5298

1

0.3248

0.5275

2

0.0674

0.8253

3

0.9753

-

4

0.1003

-

Probabilities smaller than 0.05 (α) indicate significant differences between samples.
Microbial growth patterns for aerobic bacteria, coliforms and yeasts and molds showed
some significant differences when compared at different ripening times within the same sample.
When compared between samples at different ripening times, there were no significant
differences at all, which established that γ-Oryzanol did not affect the microbial growth of
aerobic bacteria, coliforms, yeast and molds in cheddar cheese during its ripening time. All
microbial growth parameters reported tended to decrease during time for the whole experiment
79

(see Figures 4.11 and 4.12 in Appendix A for graphical trend of data in Table 4.7); coliforms did
not show any growth after the second month.
4.4 Polymerase Chain Reaction
The purpose of performing PCR in the cheese was to determine if the starter culture of
cheddar cheese was affected by γ-Oryzanol. The starter culture used in the manufacture of the
cheddar cheese was a mixture of Lactococcus lactis subsp. cremoris and subsp. lactis. The
method used for the PCR was expected to identify and separate both subspecies which was
achieved as shown in Figure 4.3 (Ward et al., 1998).
In Figure 4.3, lanes 1 to 4 are the control samples, lanes 6 to 9 are the treatment samples,
lanes 5 and 10 are the 100-bp molecular ruler; lanes 1, 3, 6 and 8 are the digested samples with
the restriction endonuclease enzyme MboII and lanes 2, 4, 7 and 9 are the non-digested samples.
As indicated in Figure 4.3 the non-digested samples (lanes 2, 4, 7 and 9) show just one bright
band and that the digested samples (lanes 1, 3, 6 and 8) have two bands which represent both
subspecies of lactis.
The blurry bands in the digested samples represent the subsp. cremoris (348-bp) and the
bright bands represent the subsp. lactis (257-bp) which means that subsp. lactis was in higher
amount than cremoris in the cheese manufactured for this experiment; these results are similar to
those of Reddy et al., (1995) who reported that using Lactococcus lactis subsp. lactis and
Lactococcus lactis subsp. cremoris as starter cultures, the Lactococcus lactis subsp. lactis
together with Lactobacillus casei were the predominant bacteria.
Based on the obtained gel from the PCR, it can be concluded that Lactococcus lactis
subsp. cremoris (348-bp) and subsp. lactis (257-bp) are both present in the cheddar cheese
containing γ-Oryzanol after 4 months of maturation.
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Figure 4.3: Agarose gel (4%) of digested and non-digested products of the Y1-Y2 amplified
fragment from cheese extraction after 4 months of maturation.
4.5 Aroma Development
The pattern of aroma development during maturation in both control and treatment
samples yielded the observation of six peaks in the chromatograms obtained (Tables 4.9 and
4.10). The software used to identify the peaks could not accurately identify them but based on
data reported by Christensen and Reineccius (1995), the six peaks obtained in the experiments
mostly represent butyric acid, ethyl butyrate, ethyl caproate, 2- or 3- methyl butanal, hexanoic
acid and propionic acid, respectively, or ethyl esters of these compounds.
These tables show that there are not significant differences existing when comparing
different months of ripening in each sample within the same sample with just one exception in
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peak 2 of the control sample. The analysis of variance and a post-hoc test pointed out a lack of
significant differences in aroma development in cheese between months during the ripening
process within each peak formation. These values show that changes in the aroma development
of cheese between months based on the peaks found in the chromatograms were not
significantly different (p<0.05) for both control and treatment samples.
Table 4.9: Means and standard deviations of heights of aroma peaks of control samples without
γ-Oryzanol at different stages of maturation.
Peak
Month

1

0

2

3

4
5
6
(Kilocounts)
24.63
15.50
15.10
16.15
31.00
(6.18)ab
(3.91)a
(5.94)a
(10.39)a
(26.67)a
8.60
13.40
9.00
10.17
16.60
b
a
a
a
(2.44)
(4.91)
(2.55)
(2.75)
(4.81)a
42.17
20.20
15.70
11.90
10.10
a
a
a
a
(19.42)
(8.92)
(7.25)
(4.85)
(1.27)a
column followed by different superscripts are significantly different

9.43
(3.97)a
1
8.87
(2.80)a
2
15.23
(7.68)a
a,b
Means within same
(P<0.05).
Peaks 1, 2, 3, 4, 5 and 6 most probably represent butyric acid, ethyl butyrate, ethyl caproate, 2or 3- methyl butanal, hexanoic acid and propionic acid, respectively.
Table 4.10: Means and standard deviations of heights of aroma peaks of treated samples with γOryzanol at different stages of maturation.
Peak
Month
0

1

2

3

4
5
6
(Kilocounts)
6.47
9.27
8.93
8.70
8.47
(0.50)a
(1.27)a
(1.85)a
(1.45)a
(0.92)a
10.25
8.70
5.80
7.00
6.20
a
a
a
a
(0.0)
(0.00)
(0.00)
(0.00)
(0.00)a
31.17
11.87
9.10
6.77
6.80
a
a
a
a
(23.41)
(2.76)
(2.10)
(1.70)
(1.44)a
column followed by different superscripts are significantly different

6.87
(1.60)a
1
5.00
(0.00)a
2
5.80
(0.00)a
a
Means within same
(P<0.05).
Peaks 1, 2, 3, 4, 5 and 6 most probably represent butyric acid, ethyl butyrate, ethyl caproate, 2or 3- methyl butanal, hexanoic acid and propionic acid, respectively.
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The comparison between control and treatment samples at different stages of maturation
did not show any significant differences either, with one exception, as shown in Table 4.11,
which was at month 0 from peak 2, but the control samples showed peaks greater than the
treatment samples. This means that γ-Oryzanol may have interfered in the flavor and aroma
development in cheese. According to Parrado et al., (2003), oryzanol derived from RBO showed
capacity to inhibit lipid peroxidation and protect protein from oxidation; and according to Nanua
et al., (2000), a high-oryzanol RBO at 0.1% significantly reduced the oxidation of low-heat
whole milk powder.
Table 4.11: Probabilities of significant differences (Pr>|t|) in heights of aroma peaks between
control (without γ-Oryzanol) and treatment (with γ-Oryzanol) samples during ripening.
Peak

Month

1
2
3
4
5
6
0
0.3578
0.0357*
0.0982
0.2073
0.4943
0.2677
1
0.3578
0.6179
0.4945
0.3909
0.4242
0.3280
2
0.3988
0.5650
0.2425
0.2517
0.1588
0.0801
*Probabilities smaller than 0.05 (α) indicate significant differences between samples.
Peaks 1, 2, 3, 4, 5 and 6 most probably represent butyric acid, ethyl butyrate, ethyl caproate, 2or 3- methyl butanal, hexanoic acid and propionic acid, respectively.
Aroma development pattern for cheddar cheese containing γ-Oryzanol did not show
significant differences when compared at different ripening times within the same sample, and
the same results when compared between samples at different ripening times.
When comparing the means of the different peaks from the chromatograms between
control and treatment samples, it can be noticed that with just one exception, all the peak heights
of aroma coming from treatment samples were lower than the control samples at the same
ripening time. This may suggest that γ-Oryzanol may have inhibited the growth of bacteria that
contribute to the odor development or that the antioxidant activity of γ-Oryzanol may have
inhibited the lipolysis or proteolysis needed in the aroma development in cheddar cheese until
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certain point even that statistically speaking there were not significant differences. There is no
congruent tendency of peak heights for the main six compounds found to produce aroma in
cheddar cheese, some increased during time and some others decreased (see Figures 4.13 to 4.18
in Appendix A for graphical trend of data in Tables 4.9 and 4.10).
4.6 Oryzanol Retention
In order to compare control and treatment samples, both were run in HPLC even though
the control did not have γ-Oryzanol.

The control samples did not show any peak in the

chromatograms, and the treatment samples showed two joined peaks (see Figure 4.19 in
Appendix A for an example of chromatograms obtained). The results of γ-Oryzanol retained in
the cheese are shown in the Table 4.12; this table also shows the significant differences within
treatments at different maturation times. ANOVA and a post-hoc test indicated that γ-Oryzanol
retention analysis had significant differences (p<0.0001).
Table 4.12: Means and standard deviations of γ-Oryzanol retained in treated cheese at different
stages of maturation (per serving size).
Month

γ-Oryzanol retained (mg/28g)

0

181.41 (5.94)a

1

99.30 (0.00)b*

2

172.36 (10.94)a

3

129.85 (21.67)b

a,b

Means followed by different superscripts are significantly different (P<0.05).
* Only one sample was obtained.
The γ-Oryzanol retained showed significant differences between following months. The
results seem to show a tendency to decrease in time during maturation but without any clear
pattern (see Figure 4.20 in Appendix A for graphical tendency of data in Table 4.12 compared to
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the target value) which could be due to a poor homogenization of γ-Oryzanol at the time of
manufacture of the cheese or that the analytical method was not accurate nor precise. It was
visually evident that the cheddar cheese containing γ-Oryzanol was not well mixed since white
spots could be seen spread all over the cheese, some were bigger than others.
Even if the results of γ-Oryzanol retention in cheese do not show any expected values, it
is very important to keep in mind that the target concentration of γ-Oryzanol added in cheese was
100mg per serving size of cheddar cheese (28g). The results presented in Table 4.12 show that
the γ-Oryzanol was very well retained in the cheese and that there was some loss of it during
ripening but still above 100mg/28g of cheese as expected.
4.7 Moisture Content
Table 4.13 presents the results of moisture content of both control and treatment samples
together with significant differences between ripening times within the same sample.

The

analysis of variance and a post-hoc test indicated an existence of significant differences
(p<0.0378 for control samples and p<0.0026 for treatment samples) in moisture contents in
cheese during the ripening process. These values show that changes in moisture content of
cheese between some months were without exception significantly different (p<0.05) for both
control and treatment samples; between some other months, there were no significant differences
at all.
The statistical analysis performed to compare the means between samples (control and
treatment) produced the data presented in Table 4.14. The comparison of means in moisture
content between control and treatment samples look very similar and with similar behaviors,
with a slight decrease during ripening process, as it can been seen in Table 4.13, and the

85

probabilities seen in Table 4.14 show that there are not significantly differences between control
and treatment samples at different ripening times.
Table 4.13: Means and standard deviations of moisture content in control (without γ-Oryzanol)
and treatment (with γ-Oryzanol) samples at different stages of maturation.
Moisture content (%)
Month
Control

Treatment

0

44.55 (0.89)a

43.86 (0.49)ab

1

43.83 (0.09)ab

44.58 (0.42)a

2

41.65 (0.96)b

40.74 (0.40)c

3

42.45 (0.18)ab

42.45 (0.32)b

a,b,c

Means within same column followed by different superscripts are significantly different
(P<0.05).
Table 4.14: Probabilities of significant differences (Pr>|t|) in moisture content between control
(without γ-Oryzanol) and treatment (with γ-Oryzanol) samples during ripening.
Month

Probability (Pr>|t|)

0

0.4353

1

0.1311

2

0.3415

3

1.0000

Probabilities smaller than 0.05 (α) indicate significant differences between samples.
Albeit there were some significant differences in moisture content between months
within each sample and there were no significant differences between control and treatment
samples, it can be concluded that γ-Oryzanol did not affect the moisture content of cheddar
cheese in a significant way (see Figure 4.21 in Appendix A for graphical trend of Table 4.13).
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The maximum moisture content in cheddar cheese is 39 percent by weight (USFDA, 2002), both
samples have a moisture content of 39% which means that something was wrong with the
process used or that the pressing step should have been done longer or with higher pressure.
4.8 Free Fatty Acid Profile
The concentration of each free fatty acid was calculated based on the chromatogram
peaks and the software the GC was equipped with, the results of the free fatty acid profile for
both control and treatment samples are presented in Tables 4.29 and 4.30 in Appendix A.
ANOVA and a post-hoc test indicated that there were significant differences (p<0.05) in
the analysis of some free fatty acids, such as C4:0, C8:0, C14:0, C16:0, C18:0 and C18:2, for
both samples; C6:0, C12:0, C18:1 and C18:3 gave significant differences just in control samples,
C16:0 just in treatment samples, and C10:0 did not show any differences at all.
Tables 4.29 and 4.30 also show the significant differences between months within the
same sample, and it can be seen that there are significant differences between some contiguous
months and in some other contiguous months this differences do not exist.
The free fatty acid profile did not show any pattern during ripening when comparing the
free fatty acid content between ripening times, but it did show that the long chain free fatty acids
are more concentrated than the middle chain and short chain fatty acids.
When comparing the free fatty acid profile between samples (control and treatment) at
different stages of the maturation, the significant differences are tabulated as probabilities in
Table 4.15. It can be seen from this table that there were no significant differences in any pairwise comparison between control samples and treatment samples at any time.
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Table 4.15: Probabilities of significant differences (Pr>|t|) in texture parameters between control (without γ-Oryzanol) and treatment
(with γ-Oryzanol) samples during ripening.
Free fatty acid
Month
C4:0

C6:0

C8:0

C10:0

C12:0

C14:0

C14:1

C16:0

C16:1

C18:0

C18:1

C18:2

C18:3

0

-

0.5239

0.4073

0.3482

0.4507

0.2824

0.5956

0.5785

0.9613

0.3936

0.6372

0.2154

0.5477

1

-

0.6726

0.3283

0.5725

0.1388

0.0539

0.4665

0.1139

0.6105

0.2348

0.3159

0.3508

0.5444

2

-

-

0.4395

0.3833

0.2756

0.2165

0.9440

0.6235

0.4975

0.6491

0.5094

0.6152

0.4961

3

0.9017

0.7462

0.7955

0.7576

0.1225

0.6861

0.7460

0.5916

0.2692

0.6383

0.6398

0.9670

0.4828

Probabilities smaller than 0.05 (α) indicate significant differences between samples.
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Results of the free fatty acid profile show too much variability, maybe due to the changes
in cheese quality during the ripening process due to γ-Oryzanols’ presence. γ-Oryzanol can be
interfering with the GC analysis in some way which does not allow the quantification of the free
fatty acids efficiently or changing the interactions between the solvent and the lipid extract.
In this experiment, the total FFA content increased during the first month of maturation
but then decreased in the following two months (Figure 4.4). It is known from another study that
the total FFA content of cheese made from raw milk and pasteurized milk increases from day 1
to day 60 (Buffa et al., 2001) which puts in contradiction both studies.

Total FFA content (mg/Kg)

350
300
250
200

Control
Treatment

150
100
50
0
0

1

2

3

Ripening time (months)
Figure 4.4: Total free fatty acid content in cheese samples during ripening per Kg of cheese.
The main FFA observed in the cheese during its maturation were myristic (C14:0),
palmitic (C16:0), stearic (C18:0) and oleic (C18:1) acids (Table 4.16), representing together
approximately 80% of total FFA content, coinciding with Buffa et al. in 2001, and confirming
that the percentages of the FFA profile were similar in cheddar cheese containing γ-Oryzanol to
normal cheddar cheese evaluated in other studies.
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Another explanation for the decrease in FFA during time could be due to the fact that γOryzanol had to do with this free fatty acid behavior during ripening affecting the tendency of
FFA to increase during time. This seems to be the most logical explanation since γ-Oryzanol is
known to have a good antioxidant activity (Xu et al., 2001) which could have diminished the
lipolysis in the cheese and the subsequent increase in free fatty acids. However, the control
samples also showed this behavior which does not support the explanation above.
Table 4.16: Percentages (%) of free fatty acids (FFA) in cheese samples during ripening.
Month

0

1

2

3

FFA

C

T

C

T

C

T

C

T

c4:0

0.00

0.00

0.00

0.00

0.00

0.00

6.14

6.08

c6:0

5.95

6.50

16.49

17.70

0.00

0.00

1.20

1.19

c8:0

2.39

2.33

3.25

2.83

2.95

2.30

0.76

0.75

c10:0

1.46

1.46

1.79

0.91

1.69

1.33

1.80

1.77

c12:0

3.32

3.22

2.75

2.76

3.83

3.01

1.70

3.79

c14:0

6.92

8.16

3.46

3.37

4.57

3.56

9.46

9.25

c14:1

1.44

1.11

1.26

0.14

1.72

1.44

1.47

1.45

c16:0

16.90

16.11

12.92

12.71

13.38

14.10

30.76

29.78

c16:1

0.03

0.02

0.52

0.62

5.79

0.71

1.10

1.94

C18:0

54.87

54.11

40.51

41.42

44.92

46.03

13.98

13.61

c18:1

2.41

1.94

1.90

2.08

2.64

12.84

26.99

26.29

c18:2

1.69

1.90

0.95

1.05

13.17

14.27

3.59

3.50

c18:3

2.63

3.13

14.21

14.40

5.35

0.41

1.05

0.60

C: control samples, T: treatment samples and c: carbon atoms in FFA.
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From Table 4.16, it can also be seen the differences existing between saturated free fatty
acids and unsaturated free fatty acids in the cheese throughout the whole ripening process. The
main FFA observed are mostly saturated (no double bonds between carbon atoms) with
exception of oleic acid which is a monosaturated fatty acid.
The only conclusion that can be reached from all these analysis and results is that both
control and treatment samples of cheddar cheese in this experiment presented a similar FFA
profile in percentages basis compared to data found in other experiments (Buffa et al., 2001;
Lindsay, 1982), and that the effects of γ-Oryzanol did not have any significant effects in the
quality of cheddar cheese during maturation.
Fat plays an essential part in the flavor of cheese, albeit an indirect part, and the most
important flavor compounds originating from the fat are the free fatty acids formed by lipolysis
(Walstra et al., 1999) which can explain part of the aroma development in cheese. The free fatty
acids at the first month of maturation may have influenced more the aroma development of
cheese than at the other times since at this stage was where the highest amount of free fatty acids
was present.
The free fatty acids cause a somewhat pungent flavor. Probably, the distribution of
aroma compounds over fat and aqueous phases enhances a balanced flavor (Walstra et al., 1999).
This distribution was mostly influenced by the long chain fatty acids rather than small chain fatty
acids at all times of maturation.
4.9 Consumer Study
4.9.1 R-Index
For the traditional R-Index, the data obtained from the questionnaire was: consumer was
certain that the sample was the treatment (S), that perhaps the sample was the treatment but not
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sure (S?), that perhaps the sample was the control but not sure (N?) or that definitely the sample
was the control (N).
The calculated R-Indices and the critical R-Indices for the traditional method, including
the frequencies of S, S?, N? and N for all the attributes evaluated by the traditional R-Index
which were the overall appearance, overall color, odor, taste and overall texture are condensed in
the Table 4.17.
Table 4.17: R-Index values of traditional method for the consumer study in cheese containing γOryzanol with the attributes evaluated.
Different
Attribute

Overall

Critical

Same

R-Index

Sample

485 (S)

R-Index
S

S?

N?

N

69

10

10

10

Appearance

705 (N)

16

4

23

56

Overall

485 (S)

34

14

17

34

Color

705 (N)

10

5

18

66

485 (S)

37

16

20

24

Odor
705 (N)

13

9

28

47

485 (S)

68

13

8

9

Taste
Overall
Texture

705 (N)

28

14

21

36

485 (S)

59

12

13

13

705 (N)

19

8

28

(%)
(%)

82.1

59.7

69.4

59.7

68.1

59.7

73.7

59.7

75.3

59.7

44

485 (S) = cheese containing γ-Oryzanol; 705 (N) = cheese without γ-Oryzanol; S= different sure;
S?= different unsure; N?= same unsure; N= same sure.
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As seen in the Table 4.17, without any exception, the calculated R-Indices for all the
attributes evaluated with the traditional method (overall appearance, overall color, odor, taste and
overall texture) were greater than the critical R-Index value of 59.7 which means that the
consumer significantly noticed a difference between control and treatment samples not by
chance. The most discriminatory attributes were overall appearance (82.1%) and overall texture
(75.3%) which tells that consumer noticed better differences in these attributes than in the others,
especially for the overall appearance.
The data obtained for calculation of the R-Index by the bipolar method are tabulated in
the Table 4.18. From the Table 4.18, the consumers noticed that the treatment samples (S) were
more yellow than the control samples (N), they also were able to indicate that the treatment
sample was harder than the control sample.
Table 4.18: Frequencies of attributes evaluated with R-Index by the bipolar method and
directions of the differences.
More
Attribute

Same

Less

Total

R-Index to

More Less

be used

Sample
S+

S+?

N?

N

S-

S-?

485 (S)

27

13

12

21

19

5

40

24

705 (N)

15

9

14

48

9

3

24

12

485 (S)

40

21

12

13

9

5

61

14

705 (N)

14

9

22

41

9

5

23

14

485 (S)

22

8

14

17

24

13

30

37

705 (N)

13

5

23

43

9

5

18

14

Yellowness

More

Hardness

More

Chewiness

More/Less

485 (S) = cheese containing γ-Oryzanol; 705 (N) = cheese without γ-Oryzanol; S+= more sure;
S+?= more unsure; N?= same unsure; N= same sure; S-= less sure; S-?= less unsure.
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The calculated R-Indices and the critical R-Indices for the bipolar method with positive
direction, including the frequencies of S+, S+?, N? and N for the yellowness and hardness are
condensed in the Table 4.19.
For the chewiness, which did not show any direction for the R-Index, the calculated RIndex and critical R-Index combining S+ with S- and S+? with S-? are in the Table 4.20.
The calculated R-Indices observed in Tables 4.19 and 4.20 for all the attributes evaluated
with the bipolar method, (yellowness, hardness and chewiness) were greater than the critical RIndices values which means that the consumer, with a significant difference, noticed a difference
between control and treatment samples not by chance (probability).
Table 4:19: R-Index values of bipolar method for the consumer study in cheese containing γOryzanol with the attributes evaluated with positive direction.
More
Attribute

Same

R-Index (%)

Critical R-

more

Index (%)

66.1

59.5

73.9

58.8

Sample

485 (S)

S+

S+?

N

N?

27

13

12

21

Yellowness
705 (N)

15

9

14

48

485 (S)

40

21

12

13

Hardness
705 (N)

14

9

22

41

485 (S) = cheese containing γ-Oryzanol; 705 (N) = cheese without γ-Oryzanol; S+= more sure;
S+?= more unsure; N?= same unsure; N= same sure.
It can also be said that consumers noticed more presence of the attribute in the treatment
sample than in the control sample for the yellowness and hardness, and even if consumers could
notice differences in the chewiness between the control and treatment samples, they were not
able to notice whether these differences were more or less of the attribute in question.
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The most discriminatory attribute by the bipolar method was the hardness of the samples
which tells that consumer noticed better differences in this attribute than in the others.
Table 4:20: R-Index values of bipolar method for the consumer study in cheese containing γOryzanol with the attributes evaluated with no direction (more/less).
Combined

Same
Critical R-

Attribute

Sample

S+,

R-Index (%)

S+?,
N

Index (%)

N?

S-

S?

485 (S)

22+24

8+13

14

17

705 (N)

13+9

5+5

23

43

Chewiness

69.0

58.2

485 (S) = cheese containing γ-Oryzanol; 705 (N) = cheese without γ-Oryzanol; S+= more sure;
S+?= more unsure; N?= same unsure; N= same sure; S-= less sure; S-?= less unsure.
As a conclusion of the R-Index study in the cheddar cheese containing γ-Oryzanol
(treatment), consumers were able to differentiate between the treatment and the control samples
(normal cheddar cheese) based on overall appearance, overall color, odor, taste, overall texture,
yellowness, hardness and chewiness.

The most discriminating attribute of the cheese by

consumers was the overall appearance, and the least discriminating was the yellowness.
4.9.2 The McNemar Test
Table 4.21 describes counts, frequencies and percentages of purchase intent responses by
consumers before and after knowing the potential health benefits they could get from the γOryzanol in cheddar cheese. These data were used to calculate the difference in proportions, the
probability in purchase intent, the statistic χ2, the estimated standard error and the confidence
interval by the McNemar test (see Appendix D for the codes in SAS).
Table 4.22 shows data obtained from the McNemar test. It can be seen from this table
that a significant difference existed between the two responses, with a χ2 value of 19.2 which is
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greater than the critical χ2df 1 of 3.84. The decision of buying the cheddar cheese containing γOryzanol was influenced by the fact that consumers had been informed about the potential health
benefits of the product.
Table 4.21: Purchase intent responses for cheddar cheese containing γ-Oryzanol before and
after consumers were informed that the product contained a potentially health promoter
compound.
Purchase intent

Purchase intent after knowing of health benefits

(before)

Yes

No

Total

Yes

18 (18.18%)

1 (1.01%)

19 (19.19%)

No

22 (22.22%)

58 (58.59%)

80 (80.81%)

Total

40 (40.40%)

59 (59.60%)

99 (100.00%)

Statistic χ2

Pr> χ2

19.2

<0.0001

Table 4.22: Variables obtained in the McNemar test.
95% confidence
Difference of
interval for the
proportions
difference
0.21

(0.13,0.30)

The 95% confidence interval for the difference in proportions was calculated in order to
obtain a better understanding of the association between the two questions’ responses (Pavon,
2003). This confidence interval for the cheese explains that the probability that consumers
would buy the product after they had been informed about the potential health benefits was 0.13
to 0.30 times higher than the probability of consumers buying it before they had been informed
about the health benefits. In conclusion, it can be said that there was a significant positive

96

increase in the purchase intent of cheddar cheese containing γ-Oryzanol after consumers had
been informed about the health benefits of this compound.
4.9.3 Consumer Acceptance Test
Table 4.23 reports the mean scores and ANOVA results for the acceptability of overall
appearance, smoothness of color, odor/aroma, taste, overall texture/mouthfeel and overall liking
of the control sample and the treatment sample containing γ-Oryzanol (see Appendix D for the
codes in SAS). The analysis of variance and a post-hoc test indicated an existence of differences
in acceptability of odor/aroma, taste, overall texture/mouthfeel and overall liking of both
samples.
Table 4.23: Means, standard deviations and analysis of variance for acceptability attributes of
the control (without γ-Oryzanol) and treatment (with γ-Oryzanol) samples.
Cheese sample
Attribute

Pr>F
Control

Treatment

Overall Appearance

6.04 (1.73)a

5.62 (2.00)a

0.1146

Smoothness of color

6.22 (1.65)a

5.82 (1.75)a

0.0988

Odor/Aroma

6.21 (1.63)a

5.24 (1.50)b

<0.0001

Taste

5.52 (2.16)a

4.04 (1.94)b

<0.0001

Mouthfeel

5.84 (1.97)a

4.68 (1.72)b

<0.0001

Overall Liking

5.60 (1.79)a

4.07 (1.82)b

<0.0001

a,b

Means within same row followed by different superscripts are significantly different (P<0.05).
The scores in Table 4.23 show, without any exception, that for all the attributes, the

consumers gave lower scores to the treatment samples than to the control samples. This means
that they liked the cheddar cheese containing γ-Oryzanol less than the normal cheddar cheese.
These differences in the scores between both samples are significant for the aroma, taste,
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mouthfeel and overall liking but not for the overall appearance and color. Therefore, consumers
liked in the same scale the overall appearance and color, but they differentiate between samples
when evaluating the aroma, taste, mouthfeel and overall liking.
Multivariate analysis of variance (MANOVA) indicated that both the control and the
treatment samples were significantly different when the effects sensory acceptability scores were
considered simultaneously with probabilities of less than 0.0001 for all, Wilks’ Lambda, Pillai’s
Trace, Hotelling-Lawley Trace and Roy’s Greatest Root statistic. These probabilities prove the
results obtained from ANOVA.
To get a better understanding of such a difference, Descriptive Discriminant Analysis
was performed. The first dimension of pooled within canonical structure (CAN 1) were used to
identify discriminating attributes; these values are shown in Table 4.24.
Table 4.24: Canonical structure of attributes describing the cheese samplesa.
Attribute

CAN 1

Overall Appearance

0.21

Smoothness of Color (yellowness)

0.24

Odor/Aroma

0.64*

Taste

0.76*

Overall Texture/Mouthfeel

0.66*

Overall Liking

0.88*

a

CAN1 is based on pool within group variances.
* Discriminating sensory attributes.
The canonical coefficients seen in Table 4.24 indicate that overall appearance and
smoothness of color were not critical discriminant attributes in the sensory evaluation of cheese,
whereas, aroma, taste, mouthfeel and overall liking were discriminant attributes with overall
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liking being the most discriminant attribute with the highest canonical coefficient of 0.88 and
overall appearance the least discriminant with a canonical coefficient of 0.21. This means that
overall liking is the attribute giving more contribution to the sensory evaluation of cheese,
followed by taste, then mouthfeel and aroma.
For the attributes evaluated with a yes/no scale in the questionnaire, the data is tabulated
in the Table 4.25, from which, part was used for McNemar test and other for a logistic analysis.
Table 4.25: Frequencies and percentages of attributes evaluated in control (without γ-Oryzanol)
and treatment (with γ-Oryzanol) cheese samples with a yes/no scale.
Sample
Question

Control

Treatment

Yes

No

Yes

No

45 (50.00%)

45 (50.00%)

74 (81.32%)

17 (18.68%)

74 (74.75%)

25 (25.25%)

36 (36.73%)

62 (63.27%)

56 (56.00%)

44 (44.00%)

19 (19.00%)

81 (81.00%)

66 (66.67%)

33 (33.33%)

40 (40.40%)

59 (59.60%)

Did you detect undesirable
bitterness aftertaste?
Is this product acceptable?
Would you buy this product if
it were commercially
available?
Would you buy this product if
it contained oryzanol, an
antioxidant and potential
cholesterol reducing
compound from rice bran?
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The logistic analysis performed using the acceptability of the product as a response
variable produced the point estimates and probabilities presented in Table 4.26 when comparing
with all sensory attributes.
The highest point estimate from the logistic analysis in Table 4.26 is the overall liking
and with significant difference; the odds ratio estimate of overall liking has a value of 2.85 which
means that this attribute is the most important for changing the acceptability of the product, and
if the overall liking score increased 1.0 unit from the 9-point hedonic scale, the probability of the
product to be acceptable would increase 2.85 times.
Table 4.26: Odds ratio estimates and probabilities (Pr>χ2) for logistic regression models using
acceptability as a response variable.
Attribute

Pr>χ2

Odds ratio estimate

Overall Appearance

0.1020

1.38

Smoothness of color

0.0893

0.70

Odor/Aroma

0.6598

0.92

Taste

0.7981

1.06

Overall Texture/Mouthfeel

0.5187

1.13

Overall Liking

<0.0001*

2.85

* Probabilities smaller than 0.05 (α) indicate significant differences.
When using the responses in the questionnaire of buying the product if it were
commercially available (before consumer are informed of the potential health benefits of the
product) as a response variable for the logistic analysis of the product, the data is presented in the
Table 4.27 with point estimates and probabilities when all sensory attributes are evaluated.
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From the Table 4.27, it can be seen that overall liking and overall texture/mouthfeel have
the highest point estimates with significant differences. This means that these attributes are the
most important for changing the purchase intent of the product; if the overall liking score
increased 1.0 unit from the 9-point hedonic scale, the probability of the product to be purchased
would increase 3.39 times, and if the overall texture/mouthfeel score augmented 1.0 unit, the
probability of the product to be purchased would increase 2.24 times.
Table 4.27: Odds ratio estimates and probabilities (Pr>χ2) for logistic regression models using
purchase intent before knowing about health benefits as a response variable.
Attribute

Pr>χ2

Odds ratio estimate

Overall Appearance

0.1365

1.43

Smoothness of color

0.0673

0.59

Odor/Aroma

0.1345

0.71

Taste

0.6421

1.12

Overall Texture/Mouthfeel

0.0036*

2.24

Overall Liking

0.0005*

3.39

* Probabilities smaller than 0.05 (α) indicate significant differences.
After knowing the prediction in purchase intent of potential consumers before they have
been informed of the health benefits of the product, knowing which attributes significantly
differentiate and predict the purchase intent and at what ratio these changes after consumers have
been informed of the health benefits of the product completes the logistic analysis.
When using the responses in the questionnaire of buying the product if it were
commercially available (after consumer have been informed of the potential health benefits of
the product) as a response variable for the logistic analysis of the product, the data is presented in
the Table 4.28 with point estimates and probabilities when all sensory attributes are evaluated.
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Table 4.28: Odds ratio estimates and probabilities (Pr>χ2) for logistic regression models using
purchase intent after knowing about health benefits as a response variable.
Attribute

Pr>χ2

Odds ratio estimate

Overall Appearance

0.1657

1.24

Smoothness of color

0.9793

1.00

Odor/Aroma

0.5992

1.08

Taste

0.2920

1.21

Overall Texture/Mouthfeel

0.7400

0.95

Overall Liking

0.0316*

1.58

* Probabilities smaller than 0.05 (α) indicate significant differences.
The highest point estimate from the logistic analysis in Table 4.28 is the overall liking
followed by the overall appearance, but just the former shows significant differences, thus
overall appearance is not useful; the odds ratio estimate of overall liking has a value of 1.58
which means that this attribute is the most important for changing the purchase intent of the
product after consumers have been informed of the potential health benefits of it; if the overall
liking score increased 1.0 unit from the 9-point hedonic scale, the probability of the product to be
acceptable would increase 1.58 times after knowing the health benefits of it.
If the estimated odd ratios used to predict consumer purchase intent that were identified
for buying the product if it were commercially available for both before and after consumer have
been informed of the potential health benefits of the product are compared to each other, it can
be seen that just the attribute overall liking is common for both purchase intents (before and
after), and that the mouthfeel is not an important predictor for purchase intent after knowing the
health benefits. This leaves the overall liking attribute as the only predictor that is critical in the
purchase intent.
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The odds point estimate for predicting the purchase intent before knowing of the health
benefits is 3.39 and after consumers are informed of the potential health benefit of the product, it
decreases to 1.58, which shows that consumers are willing to compromise the overall liking of
the cheese merely to get the health benefits of the product.
The overall liking score for the cheese containing γ-Oryzanol was 5.6 (between like
slightly and neither like nor dislike), and the prediction for purchase intent would be that
consumers are willing to go to an overall liking score of 3.5 (between dislike moderately and
dislike slightly) and still purchase the cheese in order to get the health benefits of it.
The attributes were analyzed individually to predict changes in acceptability and
purchase intent in case all attributes together did not show any significant responses. All of them
showed significant differences when compared with the acceptability and with buying intent
before and after consumers know about the health benefits of the product.
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CHAPTER 5. CONCLUSIONS
Color analysis showed changes in the quality of the cheese during ripening. Some were
significant some others were not significant, but there is not a clear tendency or pattern.
Texture profile analysis showed that there were changes in the quality of the cheese
during maturation for control and treatment samples, but that there were no significant changes
when γ-Oryzanol was added to cheese and compared to a control.
Microbial growth based on aerobic bacteria presented non significant changes for all the
period of evaluation of the cheese; however, coliform counts showed differences because there
was no growth of coliforms after the second month of evaluation.
Aroma development in cheese did not present any significant differences during
maturation nor between control and treatment samples at different stages of ripening, but the
peaks for the control samples were slightly larger than the treatment samples. The aroma
development may have been inhibited by the antioxidant activity of γ-Oryzanol decreasing the
lypolisis, proteolysis precursors of part of the flavor and aroma in cheese.
The polymerase chain reaction confirmed that Lactococcus lactis subsp. cremoris and
subsp. lactis are both present in the cheddar cheese containing γ-Oryzanol.
Even if the results obtained of γ-Oryzanol in cheese do not show any clear pattern, γOryzanol was very well retained in the cheese and there were some losses of it during ripening
but the target of 100mg per serving size of cheddar cheese (28g) was reached.
γ-Oryzanol did not affect the moisture content of cheddar cheese in a significant way.
The manufacture procedure used to make the cheddar cheese yielded a product that will not
comply the FDA regulations because it must have a maximum moisture content in cheddar
cheese is 39 percent by weight which is not the case for the cheese made for this experiment.
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This situation may limit the potential use of γ-Oryzanol in cheese as a functional ingredient or
the manufacturing procedure used.
The free fatty acid profile of both control and treatment samples of cheddar cheese in this
experiment did not show any pattern or behavior that can give some idea of the effects of γOryzanol in the cheese. The only thing that can be said is that the FFA profile obtained in this
experiment presented a similar FFA profile in percentages basis when compared to data found in
other experiments.

Therefore, the effects of γ-Oryzanol did not make any significant

differentiation in the quality of cheddar cheese during maturation.
ANOVA and post-hoc test determined that all quality parameters evaluated in control and
treatment cheese samples had significant differences during maturation. However, the twosample t-test indicated that in most cases, γ-Oryzanol did not produce significant differences in
the quality of the cheddar cheese.
Both R-Index methods (traditional and bipolar) produced some important facts about the
sensory evaluation of cheddar cheese containing γ-Oryzanol.

First, the consumer, with a

significant difference noticed a difference between control and treatment samples not by any
chance (probability); the most discriminatory attributes were overall appearance and overall
texture which tells that consumer noticed better differences in these attributes than in the others,
especially for the overall appearance. The consumers noticed that the treated samples were more
yellow than the control; they also were able to differentiate that the treatment sample was harder
than the control sample; and last, but not less important, that for the chewiness of the samples,
the consumers were not able to differentiate between control and treatment samples.
It can also be said that consumers noticed more presence of the attribute in the treatment
sample than in the control sample for the yellowness and hardness. Also, even if consumers
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could notice differences in the chewiness between the control and treatment samples, they were
not able to notice whether these differences were more or less of the attribute in question.
The most discriminatory directional attribute was the hardness of the samples which tells
that consumer noticed better positive or negative differences in this attribute than in the others.
The most discriminating attribute of all was the overall appearance, and the least discriminating
was the yellowness.
In other words, consumers were able to differentiate between the treatment containing γOryzanol and the control (normal cheddar cheese), based on overall appearance, overall color,
odor, taste, overall texture, yellowness, hardness and chewiness, but mainly with overall
appearance, texture, taste and hardness.
By means of the McNemar test, it was found out that the decision of buying the cheddar
cheese containing γ-Oryzanol was influenced with the fact that consumers had been informed
about the potential health benefits of the product. This test also found out that the probability
consumers would buy the product after they had been informed about the health benefits of it
was 0.13 to 0.30 times higher than the probability of consumers buying it before they had been
informed about the health benefits. So, there was a significant positive increase in the purchase
intent of cheddar cheese containing γ-Oryzanol after consumers had been informed about the
health benefits of this compound.
The consumer acceptance test of cheese containing γ-Oryzanol indicated an existence of
significant differences in the attributes of odor/aroma, taste, overall texture/mouthfeel and
overall liking of both samples but not for overall appearance and smoothness of color.
Consumers gave lower scores to the cheese containing γ-Oryzanol than to the control
samples which means that they liked less the cheddar cheese with extra health benefits with γ-
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Oryzanol than the normal cheese. Consumers liked at the same level the overall appearance and
color of the cheeses, but they differentiated between sample when evaluating the aroma, taste,
mouthfeel and overall liking.
From the DDA, it was found out that the overall liking attribute was the most
discriminant attribute for cheese which suggests that this attribute is contributing more to the
sensory evaluation of cheese, followed by taste, then mouthfeel and aroma.

The least

discriminant attribute for cheese was the overall appearance meaning that this attribute does not
contribute in anything for the sensory evaluation of it.
The logistic regression analysis has shown overall liking is the most important attribute
for changing the acceptability of the product, and if the overall liking scores increased 1.0 unit
from the 9-point hedonic scale, the probability of the product to be acceptable would increase
2.85 times.
Evaluating the purchase intent before consumers are informed of the health benefits of
the product determined that overall liking is still the most important attribute for changing the
purchase intent, followed by overall texture/mouthfeel; however, if the overall liking score
increased 1.0 unit from the 9-point hedonic scale, the probability of the product to be purchased
would increase 3.39 times which is higher than 2.85 for acceptability. Also, if the overall
texture/mouthfeel score augmented 1.0 unit, the probability of the product to be purchased would
increase 2.24 times.
When evaluating the purchase intent after consumers are informed of the health benefits
of the product, the logistic regression determined that overall liking was still the most important
attribute for changing the purchase intent, followed by the overall appearance. However, only
overall liking shows significant differences so overall appearance is not useful; and if the overall
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liking score increased 1.0 unit from the 9-point hedonic scale, the probability of the product to be
acceptable would increase 1.58 times after knowing the health benefits of it.
This value of 1.58 is smaller than the values when purchase intent before knowing about
the health benefits was evaluated (3.39), which shows that consumers are willing to compromise
the overall liking of the cheese merely to get the health benefits of the product.
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APPENDIX A. FIGURES AND TABLES OF ANALYSES RESULTS
a. TEXTURE
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Figure 4.5: Hardness of control and treatment cheese samples during maturation.
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Figure 4.6: Cohesiveness of control and treatment cheese samples during maturation.
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Figure 4.7: Gumminess of control and treatment cheese samples during maturation.
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Figure 4.8: Chewiness of control and treatment cheese samples during maturation.

117

0.014
Springiness (m)

0.012
0.01
0.008

Control
Treatment

0.006
0.004
0.002
0
0

1

2

3

4

Ripening time (months)

Resilience

Figure 4.9: Springiness of control and treatment cheese samples during maturation.
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Figure 4.10: Resilience of control and treatment cheese samples during maturation.
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b. MICROBIAL GROWTH
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Figure 4.11: Total aerobic bacteria growth in control and treatment cheese samples during
ripening.
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Figure 4.12: Total coliform growth in control and treatment cheese samples during maturation.
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c. AROMA DEVELOPMENT
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Figure 4.13: Aroma development of peak 1 in control and treatment samples during ripening.
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Figure 4.14: Aroma development of peak 2 in control and treatment samples during ripening.
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Figure 4.15: Aroma development of peak 3 in control and treatment samples during ripening.
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Figure 4.16: Aroma development of peak 4 in control and treatment samples during ripening.
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Figure 4.17: Aroma development of peak 5 in control and treatment samples during ripening.
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Figure 4.18: Aroma development of peak 6 in control and treatment samples during ripening.
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d. ORYZANOL RETENTION
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Treatment
Figure 4.19: Chromatography of oryzanol in cheese.
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Figure 4.20: Oryzanol retention in treatment samples during maturation (Target=100mg).
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Figure 4.21: Moisture content in control and treatment cheese samples during ripening.
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f. FREE FATTY ACID PROFILE
Table 4.29: Means and standard deviations of main free fatty acids in control samples of cheese without γ-Oryzanol at different
stages of maturation.
Free fatty acid (mg/Kg)*
Month

0

C4:0

C6:0

C8:0

C10:0

C12:0

C14:0

C14:1

C16:0

C16:1

C18:0

C18:1

C18:2

C18:3

0.00

8.53

3.39

2.06

4.71

9.82

2.00

23.94

0.04

77.76

3.42

2.38

3.66

(0.56)b

(1.44)a

(0.46)a

(2.64)ab

(0.01)a

(9.44)ab

(0.38)b

(0.01)a

(0.68)b

3.70

4.41

1.66

37.25

1.53

117.79

5.48

2.78

42.08

(0.02)a

(4.90)a

(0.49)a

(24.24)a

(0.78)b

(0.67)a

(15.90)a

1.66

13.35

5.11

44.89

2.54

13.22

4.69

(0.02)a

(5.08)b

(6.05)a

(5.83)a

(5.91)b

(0.00)b
0.00

1

(0.00)b
0.00

2

3

(0.00)b

(2.77)b (0.38)ab (0.22)a
0.00

2.84

1.63

(0.00)b (0.11)ab (0.05)a
0.00

2.84

1.63

(0.00)b (0.11)ab (0.05)a

(0.11)bc (0.16)b
3.70

4.41

(0.11)bc (0.16)b

(17.58)bc (0.08)b

5.88

1.14

0.72

1.71

1.65

8.99

1.40

29.23

1.07

13.29

25.66

3.37

0.97

(1.58)a

(0.07)b

(0.06)b

(0.14)a

(0.86)c

(0.76)a

(0.12)a

(2.43)ab

(0.49)a

(1.17)c

(2.20)a

(0.80)a

(0.54)b

a,b,c

Means within same column followed by different superscripts are significantly different (P<0.05).
* Also parts per million (PPM) in cheese wet basis.
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Table 4.30: Means and standard deviations of main free fatty acids in treated samples of cheese with γ-Oryzanol at different stages of
maturation.
Free fatty acid (mg/Kg)*
Month

0

1

2

3

C4:0

C6:0

C8:0

C10:0

C12:0

C14:0

C14:1

C16:0

C16:1

C18:0

C18:1

C18:2

C18:3

0.00

10.28

3.67

2.30

5.08

12.92

1.76

25.39

0.04

85.24

3.08

2.98

4.99

(0.00)b

(1.65)a

(0.09)b

(0.17)a

(0.11)a

(2.64)a

(0.30)a

(0.26)a

(0.01)c

(2.67)a

(0.78)a

(0.30)b

(2.53)a

0.00

37.82

5.24

1.39

5.37

6.49

0.25

24.64

1.24

81.11

4.12

2.06

30.04

(1.88)a

(1.06)a

(0.97)b

(0.00)b (26.40)a (0.44)a

(0.06)b (4.42)ab (0.46)ab (19.11)a

(1.22)a

(0.51)b (17.34)a

17.28

16.69

0.00

0.00

2.60

1.50

3.39

4.00

1.64

15.76

0.80

51.57

(0.00)b

(0.00)a

(0.34)b

(0.15)a

(0.27)a

(0.28)b

(0.29)a

(0.65)b

(0.09)bc

(2.88)ab

5.71

1.12

0.71

1.67

3.57

8.70

1.36

27.99

1.82

12.79

24.71

3.32

0.56

(0.09)a

(0.07)a

(0.04)c

(0.10)a

(1.33)a

(0.08)a

(0.57)b

(1.09)a

(1.20)b

(0.02)a

(0.61)a (0.45)ab (0.07)a

a,b,c

Means within same column followed by different superscripts are significantly different (P<0.05).
* Also parts per million (PPM) in cheese wet basis.
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(21.46)a (5.94)a

0.46
(0.00)a

APPENDIX B. CONSENT FORM FOR CONSUMER STUDY
RESEARCH CONSENT FORM
I, _____________________, agree to participate in the research entitled “Sensory Difference and
Consumer Acceptance of Cheddar Cheese,” which is being conducted by Witoon
Prinyawiwatkul of the Department of Food Science at Louisiana State University, phone number
(225)578-5188.
I understand that participation is entirely voluntary and whether or not I participate will not
affect how I am treated on my job. I can withdraw my consent at any time without penalty or loss
of benefits to which I am otherwise entitled and have the results of the participation returned to
me, removed from the experimental records, or destroyed. One hundred consumers will
participate in this research. For this particular research, about 30-35 min participation will be
required for each consumer.
The following points have been explained to me:
1. In any case, it is my responsibility to report prior participation to the investigators any
allergies I may have.
2. The reason for the research is to gather information on consumer sensory acceptability of
cheddar cheese containing oryzanol (rice bran component). The benefit that I may expect
from it is a satisfaction that I have contributed to solution and evaluation of problems relating
to such examinations.
3. The procedures are as follows: One control and two coded samples will be placed in front of
me, and I will evaluate them by normal standard methods and indicate my evaluation on
score sheets. All procedures are standard methods as published by the American Society for
Testing and Materials and the Sensory Evaluation Division of the Institute of Food
Technologists.
4. Participation entails minimal risk: The only risk which can be envisioned is that of an allergic
reaction to cheese and rice products. However, because it is known to me beforehand that
the foods to be tested contain common food ingredients, the situation can normally be
avoided.
5. The results of this study will not be released in any individual identifiable form without my
prior consent unless required by law.
6. The investigator will answer any further questions about the research, either now or during
the course of the project.
The study has been discussed with me, and all of my questions have been answered. I understand
that additional questions regarding the study should be directed to the investigators listed above.
In addition, I understand the research at Louisiana State University AgCenter that involves
human participation is carried out under the oversight of the Institutional Review Board.
Questions or problems regarding these activities should be addressed to Dr. David Morrison,
Assistant Vice Chancellor of LSU AgCenter at 578-8236. I agree with the terms above.
_______________________________
Signature of Investigator

________________________________
Signature of Participant

Date: __________________________

Witness: _________________________
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APPENDIX C. QUESTIONNAIRE FOR CONSUMER STUDY
DEMOGRAPHIC SURVEY: All information collected will not be identified with your name.
1. What is your age group? (Please check one)
18-24 years____
45-54 years____

25-34 years____
55-64 years____

2. What is your gender?

35-44 years_______
Over 64 years______

Male____________

Female_____________

3. Which do you consider yourself to be? (Please check one)
African-American___________ Hispanic/Spanish______________
Asian-American___________ White (Caucasian)_____________
Asian_____________

Other (Please specify)
_________________

4. Level of education? (Please check one)
Less than high school_____
High school_____

Some college_____
Completed college_____

Graduate (M.S., M.A., Ph.D., Ed.)______

5. Which of these categories best describes your gross 2003 household income? (Please check one)
Under $9,999______
$40,000 – 49,999______
$80,000 – 89,999______

$10,000 - 19,999____
$50,000 – 59,999____
$90,000 – 99,999____

$20,000 – 29,999____
$60,000 – 69,999____
Over $100,000______
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$30,000 – 39,999____
$70,000 – 79,999____

SAMPLE No. _705____
Please evaluate the following attributes of this cheddar cheese.
1. How would you rate the OVERALL APPEARANCE of this product?
Dislike
Extremely
[ ]
1

Dislike
Very much
[ ]
2

Dislike
Dislike
Moderately Slightly
[ ]
[ ]
3
4

Neither Like
Like
nor Dislike Slightly
[ ]
[ ]
5
6

Like
Like
Moderately Very much
[ ]
[ ]
7
8

Like
Extremely
[ ]
9

2. How would you rate the SMOOTHNESS of COLOR (yellowness) of this product?
Dislike
Extremely
[ ]
1

Dislike
Very much
[ ]
2

Dislike
Dislike
Moderately Slightly
[ ]
[ ]
3
4

Neither Like
Like
nor Dislike Slightly
[ ]
[ ]
5
6

Like
Like
Moderately Very much
[ ]
[ ]
7
8

Like
Extremely
[ ]
9

Neither Like
Like
nor Dislike Slightly
[ ]
[ ]
5
6

Like
Like
Moderately Very much
[ ]
[ ]
7
8

Like
Extremely
[ ]
9

Neither Like
Like
nor Dislike Slightly
[ ]
[ ]
5
6

Like
Like
Moderately Very much
[ ]
[ ]
7
8

Like
Extremely
[ ]
9

3. How would you rate the ODOR/AROMA of this product?
Dislike
Extremely
[ ]
1

Dislike
Very much
[ ]
2

Dislike
Dislike
Moderately Slightly
[ ]
[ ]
3
4

4. How would you rate the TASTE of this product?
Dislike
Extremely
[ ]
1

Dislike
Very much
[ ]
2

Dislike
Dislike
Moderately Slightly
[ ]
[ ]
3
4

5. How would you rate the OVERALL TEXTURE/MOUTHFEEL of this product?
Dislike
Extremely
[ ]
1

Dislike
Very much
[ ]
2

Dislike
Dislike
Moderately Slightly
[ ]
[ ]
3
4

6. Did you detect undesirable bitterness aftertaste?

Neither Like
Like
nor Dislike Slightly
[ ]
[ ]
5
6
YES [ ]

Like
Like
Moderately Very much
[ ]
[ ]
7
8

Like
Extremely
[ ]
9

NO [ ]

7. Please rate your OVERALL LIKING of this product?
Dislike
Extremely
[ ]
1

Dislike
Very much
[ ]
2

Dislike
Dislike
Moderately Slightly
[ ]
[ ]
3
4

8. Is this product ACCEPTABLE?

YES [ ]

Neither Like
Like
nor Dislike Slightly
[ ]
[ ]
5
6

Like
Like
Moderately Very much
[ ]
[ ]
7
8

Like
Extremely
[ ]
9

NO [ ]

9. Would you BUY this product if it were commercially available?

YES [ ]

NO [ ]

10. Would you BUY this product if it contained oryzanol, an antioxidant and potential cholesterol reducing compound from rice
bran?
YES [ ]
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NO [ ]

SAMPLE No. _485____
Please evaluate the following attributes of this cheddar cheese.
1. How would you rate the OVERALL APPEARANCE of this product?
Dislike
Extremely
[ ]
1

Dislike
Very much
[ ]
2

Dislike
Dislike
Moderately Slightly
[ ]
[ ]
3
4

Neither Like
Like
nor Dislike Slightly
[ ]
[ ]
5
6

Like
Like
Moderately Very much
[ ]
[ ]
7
8

Like
Extremely
[ ]
9

2. How would you rate the SMOOTHNESS of COLOR (yellowness) of this product?
Dislike
Extremely
[ ]
1

Dislike
Very much
[ ]
2

Dislike
Dislike
Moderately Slightly
[ ]
[ ]
3
4

Neither Like
Like
nor Dislike Slightly
[ ]
[ ]
5
6

Like
Like
Moderately Very much
[ ]
[ ]
7
8

Like
Extremely
[ ]
9

Neither Like
Like
nor Dislike Slightly
[ ]
[ ]
5
6

Like
Like
Moderately Very much
[ ]
[ ]
7
8

Like
Extremely
[ ]
9

Neither Like
Like
nor Dislike Slightly
[ ]
[ ]
5
6

Like
Like
Moderately Very much
[ ]
[ ]
7
8

Like
Extremely
[ ]
9

3. How would you rate the ODOR/AROMA of this product?
Dislike
Extremely
[ ]
1

Dislike
Very much
[ ]
2

Dislike
Dislike
Moderately Slightly
[ ]
[ ]
3
4

4. How would you rate the TASTE of this product?
Dislike
Extremely
[ ]
1

Dislike
Very much
[ ]
2

Dislike
Dislike
Moderately Slightly
[ ]
[ ]
3
4

5. How would you rate the OVERALL TEXTURE/MOUTHFEEL of this product?
Dislike
Extremely
[ ]
1

Dislike
Very much
[ ]
2

Dislike
Dislike
Moderately Slightly
[ ]
[ ]
3
4

6. Did you detect undesirable bitterness aftertaste?

Neither Like
Like
nor Dislike Slightly
[ ]
[ ]
5
6
YES [ ]

Like
Like
Moderately Very much
[ ]
[ ]
7
8

Like
Extremely
[ ]
9

NO [ ]

7. Please rate your OVERALL LIKING of this product?
Dislike
Extremely
[ ]
1

Dislike
Very much
[ ]
2

Dislike
Dislike
Moderately Slightly
[ ]
[ ]
3
4

8. Is this product ACCEPTABLE?

YES [ ]

Neither Like
Like
nor Dislike Slightly
[ ]
[ ]
5
6

Like
Like
Moderately Very much
[ ]
[ ]
7
8

Like
Extremely
[ ]
9

NO [ ]

9. Would you BUY this product if it were commercially available?

YES [ ]

NO [ ]

10. Would you BUY this product if it contained oryzanol, an antioxidant and potential cholesterol reducing compound from rice
bran?
YES [ ]
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NO [ ]

Part I: VISUAL. Please evaluate each cheddar cheese sample by LOOKING and comparing it with the labeled
CONTROL sample.
Sample ID
705
485
Sample ID
705
485
Sample ID
705
485

Same
I am sure

OVERALL APPEARANCE
Same
Different
I am not sure
I am not sure

Different
I am sure

Same
I am sure

OVERALL COLOR
Same
Different
I am not sure
I am not sure

Different
I am sure

More
I am sure

More
I am not sure

YELLOWNESS
Same
I am not sure

Same
I am sure

Less
I am sure

Less
I am not sure

Part II: ODOR. Please evaluate each cheddar cheese sample by SMELLING and comparing it with the labeled
CONTROL sample.
Sample ID
705
485

Same
I am sure

ODOR
Same
I am not sure

Different
I am not sure

Different
I am sure

Part III: TASTE AND TEXTURE. Please evaluate each cheddar cheese sample by TASTING and CHEWING
and comparing it with the labeled CONTROL sample.
Sample ID
705
485

Sample ID
705
485
Sample ID
705
485
Sample ID
705
485

Same
I am sure

Same
I am sure

TASTE
Same
I am not sure

Different
I am not sure

Different
I am sure

OVERALL TEXTURE
Same
Different
I am not sure
I am not sure

Different
I am sure

More
I am sure

More
I am not sure

HARDNESS
Same
I am not sure

Same
I am sure

Less
I am sure

Less
I am not sure

More
I am sure

More
I am not sure

CHEWINESS
Same
I am not sure

Same
I am sure

Less
I am sure

Less
I am not sure
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APPENDIX D. SAS CODES
a. COLOR AND TEXTURE
dm 'log;clear;output;clear';
data one;
input sample $ rep month hard cohes adhes gummi chewi spring resil
LL
aa
bb
cc
hh;
datalines;
inserted data;
proc sort; by sample month;
proc means mean std n maxdec=2;by sample month;
var hard--hh;
proc sort; by sample;
proc glm;by sample;
class month;
model hard--hh = month;
means month/tukey lines;
proc sort; by month;
proc ttest; by month;
**//independent ttest;
class sample;
var hard--hh;
run;
b. MICROBIAL GROWTH
dm 'log;clear;output;clear';
data one;
input sample $ rep month logAPC logCOL;
datalines;
inserted data;
proc sort; by sample month;
proc means mean std n maxdec=2;by sample month;
var logAPC--logCOL;
proc sort; by sample;
proc glm; by sample;
class month;
model logAPC--logCOL = month;
means month/tukey lines;
proc sort; by month;
proc ttest; by month;
**//independent ttest;
class sample;
var logAPC--logCOL;
run;
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c. AROMA
dm 'log;clear;output;clear';
data one;
input sample $ month peak1 peak2 peak3 peak4 peak5 peak6;
datalines;
inserted data;
proc sort; by sample month;
proc means mean std n maxdec=2;by sample month;
var peak1--peak6;
proc sort; by sample;
proc glm; by sample;
class month;
model peak1--peak6 = month;
means month/tukey lines;
proc sort; by month;
proc ttest; by month;
**//independent ttest;
class sample;
var peak1--peak6;
run;
d. ORYZANOL RETENTION
dm 'log;clear;output;clear';
data one;
input sample $ rep month oryzanol;
datalines;
inserted data;
proc sort; by month;
proc means mean std n maxdec=2;by month;
var oryzanol;
proc glm;
class month;
model oryzanol = month;
means month/tukey lines;
run;
e. MOISTURE CONTENT
dm 'log;clear;output;clear';
data one;
input sample $ rep month moisture;
datalines;
inserted data;
proc sort; by sample month;
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proc means mean std n maxdec=2;by sample month;
var moisture;
proc sort; by sample;
proc glm; by sample;
class month;
model moisture = month;
means month/tukey lines;
proc sort; by month;
proc ttest; by month;
**//independent ttest;
class sample;
var moisture;
run;
f. FREE FATTY ACID PROFILE
dm 'log;clear;output;clear';
data one;
input sample $ rep month C4 C6 C8 C10 C12 C14 C141 C16
C161 C18 C181 C182 C183;
datalines;
inserted data;
proc sort; by sample month;
proc means mean std n maxdec=2;by sample month;
var C4--C183;
proc sort; by sample;
proc glm; by sample;
class month;
model C4--C183 = month;
means month/tukey lines;
proc sort; by month;
proc ttest; by month;
**//independent ttest;
class sample;
var C4--C183;
run;
g. THE MCNEMAR TEST
dm 'log;clear;output;clear';
data one;
Input sample buy buyif count;
datalines;
inserted data;
run;
proc freq; weight count;
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tables buy*buyif/agree; by sample;
run;
h. CONSUMER ACCEPTANCE (MANOVA, DDA AND LOGISTIC REGRESSION)
dm 'log;clear;output;clear';
data one;
input consumer sample gender appear color aroma
taste mouthf bitter olike accept buy buyif;
datalines;
inserted data;
proc sort; by sample;
proc means mean std n maxdec=2;by sample;
var appear color aroma taste mouthf olike;
proc freq; by sample;
tables bitter accept buy buyif;
proc anova;
class sample;
model appear color aroma taste mouthf olike = sample;
means sample/tukey lines;
Proc candisc out=outcan mah;
class sample;
var appear color aroma taste mouthf olike;
Proc logistic data = one;
model accept = appear color aroma taste mouthf olike;
Proc logistic data = one;
model accept = appear;
Proc logistic data = one;
model accept = color;
Proc logistic data = one;
model accept = aroma;
Proc logistic data = one;
model accept = taste;
Proc logistic data = one;
model accept = mouthf;
Proc logistic data = one;
model accept = olike;
Proc logistic data = one;
model buy = appear color aroma taste mouthf olike;
Proc logistic data = one;
model buy = appear;
Proc logistic data = one;
model buy = color;
Proc logistic data = one;
model buy = aroma;
Proc logistic data = one;
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model buy = taste;
Proc logistic data = one;
model buy = mouthf;
Proc logistic data = one;
model buy = olike;
Proc logistic data = one;
model buyif = appear color aroma taste mouthf olike;
Proc logistic data = one;
model buyif = appear;
Proc logistic data = one;
model buyif = color;
Proc logistic data = one;
model buyif = aroma;
Proc logistic data = one;
model buyif = taste;
Proc logistic data = one;
model buyif = mouthf;
Proc logistic data = one;
model buyif = olike;
run;
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APPENDIX E. CERTIFICATE OF ANALYSIS OF GAMMA-ORYZANOL
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